This archive includes all weekly updates of the figures on the COVID-19 vaccination programme in the Netherlands.

19 October 2021| 4:00 PM

Vaccination figures: 11 to 17 October 2021


By Sunday 17 October, it is estimated that more than 23.8 million vaccinations had been administered in the Netherlands. More than 12.9 million of those were first vaccinations, and more than 10.8 million were second vaccinations. It is estimated that 87.1% of all people over 18 have received at least one vaccination, and 83.5% are fully vaccinated. Looking at all people aged 12 years and older, 84.9% have received at least one vaccination, and 81.4% are fully vaccinated.

Slight increase in turnout and vaccination coverage

A slight increase can still be observed in turnout and vaccination coverage. An increase of less than 1% was observed in most age groups. In the age group of 12-17 years, the increase for a first vaccination was 1%, while the increase in full vaccination was 2%.

Most vaccinations in youngest age groups

More than 8,400 children aged 12-17 years received a first vaccination last week. 18,200 children in this age group reached full vaccination. Among young people aged 18-25 years, more than 6,400 received a first vaccination, and about 13,000 reached full vaccination. Vaccinations continue to be administered in the age groups above 25 years old, but the increase in these age groups is smaller.

Vaccination figures: 6 January – 17 October 2021

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 41 (2021), by type of vaccinator.

 

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total
GGD 91+ 1930 and earlier 26 January 2021 68,334 66,607 134,941
GGD 86-90 1931-1935 29 January 2021 189,346 185,982 375,328
GGD 81-85 1936-1940 5 February 2021 377,319 371,642 748,961
GGD 76-80 1941-1945 6 March 2021 573,493 563,820 1,137,313
GGD 71-75 1946-1950 6 April 2021 859,930 836,469 1,696,399
GGD 66-70 1951-1955 19 April 2021 800,593 770,238 1,570,831
GGD 61-65 1956-1960   141,890 150,295 292,185
GGD 56-60 1961-1965 27 April 2021 1,024,620 954,025 1,978,645
GGD 51-55 1966-1970 20 May 2021 1,033,238 749,519 1,782,757
GGD 46-50 1971-1975 26 May 2021 883,082 793,165 1,676,247
GGD 41-45 1976-1980 29 May 2021 770,603 637,718 1,408,321
GGD 36-40 1981-1985 1 June 2021 738,766 643,081 1,381,847
GGD 31-35 1986-1990 7 June 2021 737,615 626,020 1,363,635
GGD 26-30 1991-1995 11 June 2021 718,331 576,596 1,294,927
GGD 18-25 1996-2003 15 June 2021 1,167,830 815,991 1,983,821
GGD 12-17 2004-2009 22 June 2021 699,011 581,419 1,280,430
GGD Unknown Unknown   3,120 2,233 5,353
GPs (estimated)4,5     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)3,6     6 January 2021 940,106 480,556 1,420,662
Total7       12,953,456 10,894,293 23,847,749

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 41, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. 2.    The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. 
    The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). 
    People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. 
    Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
  3. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment  is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
  5. For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).  From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  6. 221,937 estimated vaccinations administered by other vaccinators, and 615,278 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
  7. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 41, 20211-6

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 84.9% 81.4%
18 years and older 2003 and before 87.1% 83.5%

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 41, 20211-6

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
  4. 4.    The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. 
    In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. 
    The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
  6. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated.  The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.

12 October 2021| 4:45 PM

Vaccination figures: 4 to 10 October 2021


By Sunday 10 October, it is estimated that more than 23.7 million vaccinations had been administered in the Netherlands. More than 12.9 million of those were first vaccinations, and more than 10.8 million were second vaccinations. It is estimated that 86.9% of all people over 18 have received at least one vaccination, and 83.2% are fully vaccinated. Looking at all people aged 12 years and older, 84.7% have received at least one vaccination, and 80.9% are fully vaccinated.

Slight increase in turnout and vaccination coverage

A slight increase can still be observed in turnout and vaccination coverage. An increase of less than 1% was observed in most age groups over the past week. In the age group of 12-17 years, the increase for a first vaccination was 1%, while the increase in full vaccination was 2%.
Looking at the increase in absolute numbers, the largest increase occurred in the youngest age groups. More than 11,000 children aged 12-17 years received a first vaccination last week, and 21,000 reached full vaccination. Among young people aged 18-25 years, more than 9,000 received a first vaccination, and 14,500 reached full vaccination. New vaccinations continue to be administered in the age groups above 25 years old, but in smaller numbers.

Vaccination figures: 6 January – 10 October 2021

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 40 (2021), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total
GGD 91+ 1930 and earlier 26 January 2021 68,315 66,572 134,887
GGD 86-90 1931-1935 29 January 2021 189,284 185,903 375,187
GGD 81-85 1936-1940 5 February 2021 377,185 371,429 748,614
GGD 76-80 1941-1945 6 March 2021 573,294 563,518 1,136,812
GGD 71-75 1946-1950 6 April 2021 859,650 835,989 1,695,639
GGD 66-70 1951-1955 19 April 2021 800,279 769,579 1,569,858
GGD 61-65 1956-1960   141,324 149,179 290,503
GGD 56-60 1961-1965 27 April 2021 1,023,748 952,458 1,976,206
GGD 51-55 1966-1970 20 May 2021 1,031,972 747,406 1,779,378
GGD 46-50 1971-1975 26 May 2021 881,455 790,586 1,672,041
GGD 41-45 1976-1980 29 May 2021 768,757 634,642 1,403,399
GGD 36-40 1981-1985 1 June 2021 736,124 638,921 1,375,045
GGD 31-35 1986-1990 7 June 2021 734,066 620,373 1,354,439
GGD 26-30 1991-1995 11 June 2021 714,100 570,412 1,284,512
GGD 18-25 1996-2003 15 June 2021 1,161,149 805,387 1,966,536
GGD 12-17 2004-2009 22 June 2021 690,275 564,367 1,254,642
GGD Unknown Unknown   3,108 2,227 5,335
GPs (estimated)4,5     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)3,6     6 January 2021 939,809 479,378 1,419,187
Total7       12,920,123 10,837,243 23,757,366

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 40, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
  3. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM  is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
  5. For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).  From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  6. 221,640 estimated vaccinations administered by other vaccinators, and 611,333 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
  7. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 40, 20211-6

Age group Birth years Turnout for at least one dose Vaccination coverage (full vaccination)
12 years and older 2009 and before 84.7% 80.9%
18 years and older 2003 and before 86.9% 83.2%

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 40, 20211-6

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
  4. The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS is displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
  6. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated.  The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.

05 October 2021| 4:45 PM

Vaccination figures: 26 September to 3 October 2021

By Sunday 3 October, it is estimated that more than 23.6 million vaccinations had been administered in the Netherlands. More than 12.8 million of those were first vaccinations, and more than 10.7 million were second vaccinations. It is estimated that 86.7% of all people over 18 have received at least one vaccination, and 82.9% are fully vaccinated. Looking at all people aged 12 years and older, 84.4% have received at least one vaccination, and 80.5% are fully vaccinated. 

Slight increase in turnout and vaccination coverage

A slight increase can still be observed in turnout and vaccination coverage. Most age groups show an increase of less than 1%. In the age group of 12-17 years, the increase is between 1 and 2%.

See the tabels and footnotes in this pdf (in Dutch)

28 September 2021| 4:00 PM

Vaccination figures: 20 to 26 September 2021

By Sunday 26 September, it is estimated that more than 23.5 million vaccinations had been administered in the Netherlands. More than 12.8 million of those were first vaccinations, and more than 10.7 million were second vaccinations. It is estimated that 86.3% of all people over 18 have received a first vaccination, and 82.4% are fully vaccinated. Looking at all people over 12 years old, 84.0% have received a first vaccination, and 80.0% are fully vaccinated. 

Slight increase in turnout and vaccination coverage

A slight increase can still be observed in turnout and vaccination coverage. For most age groups, the increase is about 1%. Full vaccination coverage increased by 2% among the age group of 12-17 years. 

Vaccination maps by municipality provide more detail 

As of this week, turnout and full vaccination coverage among people aged 12-17 years and all people over 12 can now be displayed by municipality. This completes the overviews of vaccinated age groups by municipality. 

Vaccination figures: 6 January – 26 September 2021

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 38 (2021), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose3 Total
GGD 91+ 1930 and earlier 26 January 2021 68,249 66,509 134,758
GGD 86-90 1931-1935 29 January 2021 189,137 185,739 374,876
GGD 81-85 1936-1940 5 February 2021 376,864 371,083 747,947
GGD 76-80 1941-1945 6 March 2021 572,849 562,964 1,135,813
GGD 71-75 1946-1950 6 April 2021 858,976 835,046 1,694,022
GGD 66-70 1951-1955 19 April 2021 799,370 768,377 1,567,747
GGD 61-65 1956-1960   139,759 146,953 286,712
GGD 56-60 1961-1965 27 April 2021 1,021,410 949,325 1,970,735
GGD 51-55 1966-1970 20 May 2021 1,028,484 743,090 1,771,574
GGD 46-50 1971-1975 26 May 2021 876,918 785,099 1,662,017
GGD 41-45 1976-1980 29 May 2021 763,198 628,374 1,391,572
GGD 36-40 1981-1985 1 June 2021 728,545 630,187 1,358,732
GGD 31-35 1986-1990 7 June 2021 723,272 608,867 1,332,139
GGD 26-30 1991-1995 11 June 2021 701,794 557,766 1,259,560
GGD 18-25 1996-2003 15 June 2021 1,139,248 782,641 1,921,889
GGD 12-17 2004-2009 22 June 2021 661,617 527,039 1,188,656
GGD Unknown Unknown   2,994 2,147 5,141
GPs (estimated)4,5     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)3,6     6 January 2021 932,493 472,664 1,405,157
Total7       12,811,406 10,712,787 23,524,193

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 38, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
  3. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment  is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
  5. For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).  From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  6. 214,114 estimated vaccinations administered by other vaccinators, and 600,840 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
  7. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 38, 20211-8

Age group Birth years Vaccination turnout Vaccination coverage (full vaccination)
12 years and older 2009 and before 84.0% 80.0%
18 years and older 2003 and before 86.3% 82.4%

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 38, 20211-8

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. From 14 September 2021 on, this table includes previous COVID-19 infection in calculating vaccination coverage. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
  4. The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS is displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. 
  5. People who have already had COVID-19 will only need one dose of COVID-19 vaccine.  From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated.
  6. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
  7. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated.  The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.

21 September 2021| 6:00 PM

Vaccination figures: 13–19 September 2021

By Sunday 19 September, it is estimated that 23.4 million vaccinations had been administered in the Netherlands. More than 12.7 million of those were first vaccinations, and more than 10.6 million were second vaccinations. It is estimated that 86.0% of all people over 18 have received a first vaccination, and 82.1% are fully vaccinated. Looking at all people over 12 years old, 83.5% have received a first vaccination, and 79.6% are fully vaccinated.

More vaccinations were administered in the past week than in the previous few weeks, especially in the younger age groups. As a result, turnout for the first vaccination rose more sharply than in recent weeks.

Vaccinations after COVID-19 infection now included in vaccination coverage by age and municipality

Last week’s update noted that people who have received one vaccination after previously having had COVID-19 will be included in the fully vaccinated category in the national figures from now on. From this week on, these people will also be included in the fully vaccinated category in the breakdown of vaccination coverage by age and municipality.

Data corrections

The update for this week contains two corrections resulting from ongoing improvements in how source data is processed. A quality check revealed that some vaccinations with the Janssen vaccine had previously been over-counted in calculating vaccination coverage by age group. As a result, vaccination coverage by age was overestimated slightly (by 0.9%). In contrast, on the maps showing vaccination coverage by municipality, vaccination coverage at the municipal level was underestimated (by 4.2% on average).

Vaccination figures: 6 January – 19 September 2021

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 37 (2021), by type of vaccinator.

 

Vaccinator Target group Birth year Start date2 First dose Second dose7 Total
GGD 91+ 1930 and earlier 26 January 2021 68,217 66,470 134,687
GGD 86-90 1931-1935 29 January 2021 189,028 185,636 374,664
GGD 81-85 1936-1940 5 February 2021 376,648 370,891 747,539
GGD 76-80 1941-1945 6 March 2021 572,514 562,675 1,135,189
GGD 71-75 1946-1950 6 April 2021 858,543 834,495 1,693,038
GGD 66-70 1951-1955 19 April 2021 798,747 767,621 1,566,368
GGD 61-65 1956-1960   138,742 145,588 284,330
GGD 56-60 1961-1965 27 April 2021 1,019,876 947,475 1,967,351
GGD 51-55 1966-1970 20 May 2021 1,026,248 740,401 1,766,649
GGD 46-50 1971-1975 26 May 2021 874,095 781,822 1,655,917
GGD 41-45 1976-1980 29 May 2021 759,870 624,575 1,384,445
GGD 36-40 1981-1985 1 June 2021 723,833 624,977 1,348,810
GGD 31-35 1986-1990 7 June 2021 716,833 601,918 1,318,751
GGD 26-30 1991-1995 11 June 2021 694,495 550,336 1,244,831
GGD 18-25 1996-2003 15 June 2021 1,126,531 769,223 1,895,754
GGD 12-17 2004-2009 22 June 2021 642,738 505,691 1,148,429
GGD Unknown Unknown   2,950 2,127 5,077
GPs (estimated)3,4     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)3,5     6 January 2021 925,061 495,038 1,420,099
Total6       12,741,198 10,665,876 23,407,074

 Explanation of target group and figures, in table vaccination figures

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 37, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
  3. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
  5. For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).  From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  6. 206,682 estimated vaccinations administered by other vaccinators, and 594,784  vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
  7. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 37, 20211-7 

Age group Birth years Vaccination turnout Vaccination coverage (full vaccination)
12 years and older 2009 and before 83.5% 79.6%
18 years and older 2003 and before 86.0% 82.1%

 Explanation

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 37, 20211-8

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. From 14 September 2021 on, this table includes figures for people who previously had COVID-19 in calculating vaccination coverage. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
  4. The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS is displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
  5. People who have been vaccinated by the GGD with the Janssen vaccine are included in both turnout and vaccination coverage, since this is a single-dose vaccine.
  6. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
  7. People who have already had COVID-19 will only need one dose of COVID-19 vaccine.  From 14 September 2021 on, these people will also be counted among the group of people who are fully vaccinated.
  8. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated.  The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.

14 September 2021| 6:30 PM

For an explanation of the weekly COVID-19 figures in the Netherlands, read the news:  People who had one jab after having COVID-19 now included in vaccination coverage figures for full vaccination

Vaccination figures: 6 January – 12 September 2021

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 36 (2021), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose7 Total
GGD 91+ 1930 and earlier 26 January 2021 68,194 66,435 134,629
GGD 86-90 1931-1935 29 January 2021 188,957 185,551 374,508
GGD 81-85 1936-1940 5 February 2021 376,470 370,712 747,182
GGD 76-80 1941-1945 6 March 2021 572,286 562,365 1,134,651
GGD 71-75 1946-1950 6 April 2021 858,103 833,945 1,692,048
GGD 66-70 1951-1955 19 April 2021 798,171 766,847 1,565,018
GGD 61-65 1956-1960   137,718 144,035 281,753
GGD 56-60 1961-1965 27 April 2021 1,018,326 945,542 1,963,868
GGD 51-55 1966-1970 20 May 2021 1,023,986 737,558 1,761,544
GGD 46-50 1971-1975 26 May 2021 871,221 778,144 1,649,365
GGD 41-45 1976-1980 29 May 2021 756,393 620,658 1,377,051
GGD 36-40 1981-1985 1 June 2021 719,037 619,380 1,338,417
GGD 31-35 1986-1990 7 June 2021 709,974 594,419 1,304,393
GGD 26-30 1991-1995 11 June 2021 686,663 542,111 1,228,774
GGD 18-25 1996-2003 15 June 2021 1,112,166 753,810 1,865,976
GGD 12-17 2004-2009 22 June 2021 621,582 479,543 1,101,125
GGD Unknown Unknown   2,713 1,963 4,676
GPs (estimated)3,4     15 February 2021 1,226,229 1,088,917 2,315,146
Other vaccinators (estimated)3,5     6 January 2021 925,061 493,696 1,418,757
Total6       12,673,250 10,585,631 23,258,881

 Explanation of target group and figures, in table vaccination figures

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 35, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen® . One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
  3. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
  5. For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).  From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  6. 206,682 estimated vaccinations administered by other vaccinators, and 588,295 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
  7. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

 Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 36, 20211-7 

Age group Birth years Vaccination turnout Vaccination coverage (full vaccination)
12 years and older 2009 and before 83.1% 79.0%
18 years and older 2003 and before 85.6% 81.7%

 Explanation

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
  2. People under 80 years old who have already had COVID-19 will only need one dose of COVID-19 vaccine. People who only received a first vaccination from the GGD, other than the Janssen vaccine, and had received a positive COVID-19 test result from the GGD at least 8 weeks prior to vaccination and/or self-reported having had COVID-19, are included in the calculation of the vaccination coverage. As a result, the vaccination coverage in this table may differ from the percentage for 18 years and older as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
  4. The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS is displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
  5. People who have been vaccinated by the GGD with the Janssen vaccine are included in both turnout and vaccination coverage, since this is a single-dose vaccine.
  6. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
  7. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. Since our dataset currently does not include sufficient data on this, however, for the time being these people will be counted among the group of people who have been fully vaccinated (except for those who received the Janssen vaccine).
  8. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated.
     The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday. For the calculation of turnout and vaccination coverage in this table, the denominator is an estimate of the number of young people who will turn 12 years old in the current week.

7 September 2021| 4:23 PM

Vaccination figures: 30 August – 5 September 2021

By Sunday 5 September, it is estimated that more than 23.1 million vaccinations had been administered in the Netherlands. More than 12.6 million of those were first vaccinations, and more than 10.5 million were second vaccinations. It is estimated that 85.4% of all people over 18 have received a first vaccination by now, and 77.1% are fully vaccinated. Looking at all people over 12 years old, 83.1% have received a first vaccination, and 74.3% are fully vaccinated.

Turnout for first vaccination

The RIVM vaccination update shows that turnout for a first vaccination has increased by 1%, but only in the age groups under 30 years old. It stayed the same in the age groups over 31 years old.

That does not mean that no more first vaccinations are being administered, since they still are. However, it takes approximately 150,000 vaccinations to increase vaccination turnout or coverage by 1% in all people over 12 years old. About 50,000 first vaccinations were administered this week.

Vaccination coverage

Vaccination coverage indicates what percentage of the population has been fully vaccinated.

Vaccination coverage among young people aged 12-17 increased by 7%, rising to 39%. Coverage is 41% if children born in 2009 who have not yet turned 12 are not included. Vaccination coverage among older age groups has also increased. Among people aged 18-25, vaccination coverage increased by 2%, rising to 57%, and vaccination coverage among people aged 25-65 increased by 1%.

People are currently considered fully vaccinated after receiving two vaccinations, or one vaccination with the Janssen vaccine. If a person has received one vaccination after previously having COVID-19, that person is also considered fully vaccinated. These people are currently counted in the category of ‘turnout for first vaccination’, because they have only received one vaccination. They are not yet counted in the category of ‘fully vaccinated’ because we cannot currently filter the data to sort these people out. We expect to be able to count these people as fully vaccinated in a report in the near future, which will result in a higher figure for vaccination coverage. 


Vaccination figures: 6 January – 5 September 2021

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 35 (2021), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose7 Total
GGD 91+ 1930 and earlier 26 January 2021 68,167 66,402 134,569
GGD 86-90 1931-1935 29 January 2021 188,895 185,469 374,364
GGD 81-85 1936-1940 5 February 2021 376,351 370,513 746,864
GGD 76-80 1941-1945 6 March 2021 572,097 562,069 1,134,166
GGD 71-75 1946-1950 6 April 2021 857,758 833,412 1,691,170
GGD 66-70 1951-1955 19 April 2021 797,746 766,065 1,563,811
GGD 61-65 1956-1960   137,023 142,544 279,567
GGD 56-60 1961-1965 27 April 2021 1,017,202 943,645 1,960,847
GGD 51-55 1966-1970 20 May 2021 1,022,351 774,521 1,756,908
GGD 46-50 1971-1975 26 May 2021 869,131 774,521 1,643,652
GGD 41-45 1976-1980 29 May 2021 753,875 616,792 1,370,667
GGD 36-40 1981-1985 1 June 2021 715,663 614,072 1,329,735
GGD 31-35 1986-1990 7 June 2021 705,465 586,817 1,292,282
GGD 26-30 1991-1995 11 June 2021 681,830 533,418 1,215,248
GGD 18-25 1996-2003 15 June 2021 1,102,904 737,915 1,840,819
GGD 12-17 2004-2009 22 June 2021 605,307 450,715 1,056,112
GGD Unknown Unknown   2,675 1,949 4,624
GPs (estimated)3,4     15 February 2021 1,228,627 1,088,917 2,317,544
Other vaccinators (estimated)3,5     6 January 2021 925,625 493,637 1,419,262
Total6       12,628,782 10,503,429 23,132,211

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 35, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen® . One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
  3. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
  5. For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).  From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  6. 206,682 estimated vaccinations administered by other vaccinators, and 585,133 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
  7. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 35, 2021 

Age group Birth years Vaccination turnout Vaccination coverage (full vaccination)
12 years and older 2009 and before 83.1% 74.3%
18 years and older 2003 and before 85.4% 77.1%
  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by birth year, Statistics Netherlands (CBS), January 2020.
  2. The turnout and vaccination coverage for 18 years and older reported here are also reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
  4. The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS is displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
  5. People who have been vaccinated by the GGD with the Janssen vaccine are included in both turnout and vaccination coverage, since this is a single-dose vaccine.
  6. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
  7. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. Since our dataset currently does not include sufficient data on this, however, for the time being these people will be counted among the group of people who have been fully vaccinated (except for those who received the Janssen vaccine).
  8. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated.
     The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday. For the calculation of turnout and vaccination coverage in this table, the denominator is an estimate of the number of young people who will turn 12 years old in the current week.

31 August 2021 | 4:23 PM

Vaccination figures: 23 - 29 August 2021

By Sunday 29 August, it is estimated that more than 22.9 million vaccinations had been administered in the Netherlands. More than 12.5 million of those were first vaccinations, and more than 10.3 million were second vaccinations. It is estimated that 85.2% of all people over 18 have received a first vaccination by now, and 76.5% are fully vaccinated. Looking at all people over 12 years old, 82.8% have received a first vaccination, and 73.3% are fully vaccinated. 

Turnout for first vaccination

The RIVMNational Institute for Public Health and the Environment vaccination update shows that turnout for a first vaccination has increased somewhat in the age groups under 55 years old. 51% of all young people born in 2004 through 2009 have now received their first vaccination. Young people born in 2009 who have not yet turned 12 cannot make an appointment yet. If they are not included in the calculations, then vaccination turnout in the 12-17 age group is currently 54%.  

Vaccination coverage

Vaccination coverage indicates what percentage of the population has been fully vaccinated. 

Vaccination coverage among the youngest age group increased by 9%, rising to 32%. Coverage is 34% if children born in 2009 who have not yet turned 12 are not included. Vaccination coverage among older age groups has also increased.

People are currently considered fully vaccinated after receiving two vaccinations, or one vaccination with the Janssen vaccine. If a person has received one vaccination after previously having COVID-19, that person is fully vaccinated. These people are currently counted in the category of ‘turnout for first vaccination’. We expect to be able to count these people as fully vaccinated in a report in the near future.  


Vaccination figures: 6 January – 29 August 2021

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 34 (2021), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose7 Total
GGD 91+ 1930 and earlier 26 January 2021 68,147 66,357 134,504
GGD 86-90 1931-1935 29 January 2021 188,822 185,357 374,179
GGD 81-85 1936-1940 5 February 2021 376,227 370,240 746,467
GGD 76-80 1941-1945 6 March 2021 571,888 561,594 1,133,482
GGD 71-75 1946-1950 6 April 2021 857,439 832,553 1,689,992
GGD 66-70 1951-1955 19 April 2021 797,323 764,860 1,562,183
GGD 61-65 1956-1960   136,240 139,944 276,184
GGD 56-60 1961-1965 27 April 2021 1,016,076 940,564 1,956,640
GGD 51-55 1966-1970 20 May 2021 1,020,599 729,988 1,750,587
GGD 46-50 1971-1975 26 May 2021 866,883 769,168 1,636,051
GGD 41-45 1976-1980 29 May 2021 751,260 610,711 1,361,971
GGD 36-40 1981-1985 1 June 2021 712,000 605,650 1,317,650
GGD 31-35 1986-1990 7 June 2021 700,685 575,060 1,275,745
GGD 26-30 1991-1995 11 June 2021 676,481 520,245 1,196,726
GGD 18-25 1996-2003 15 June 2021 1,092,468 714,802 1,807,270
GGD 12-17 2004-2009 22 June 2021 586,860 374,939 961,799
GGD Unknown Unknown   2,638 1,921 4,559
GPs (estimated)3,4     15 February 2021 1,228,627 1,088,917 2,317,544
Other vaccinators (estimated)3,5     6 January 2021 925,625 493,051 1,418,676
Total6       12,576,288 10,345,921 22,922,209

24 August 2021 | 5:36 PM

Vaccination figures: 16 – 22 August 2021

By Sunday 22 August, it is estimated that more than 22.6 million vaccinations had been administered in the Netherlands. More than 12.5 million of those were first vaccinations, and more than 10.1 million were second vaccinations. It is estimated that 84.9% of all people over 18 have received a first vaccination by now, and 75.7% are fully vaccinated. This week, these figures are also available for everyone over the age of 12. 82.4% of all people over 12 years old have received a first vaccination, and 72.0% are fully vaccinated. 

Turnout for first vaccination

The RIVM vaccination update shows that turnout for a first vaccination is no longer increasing in most age groups. An increase can still be observed in the younger age groups. Nearly 49% of all young people born in 2004 through 2009 have now received their first vaccination. Young people born in 2009 who have not yet turned 12 cannot make an appointment yet. If they are not included in the calculations, then vaccination turnout in the 12-17 age group is currently 52%.  

Vaccination coverage

Vaccination coverage indicates which age groups have received two vaccinations or one Janssen vaccination. Vaccination coverage among the younger age groups has continued to increase. The age group of 12-17 years has now achieved a vaccination coverage of more than 23%. Coverage is nearly 25% if children born in 2009 who have not yet turned 12 are not included. For people aged 18-25 years, vaccination coverage has increased to more than 52%, rising to 54% for people aged 26-30. In the age group of 30 years and older, vaccination coverage is still rising slightly or stabilising.

Turnout and vaccination coverage by municipality

Vaccination coverage by municipality is displayed according to people in various age groups who have received two vaccinations or one Janssen vaccination. The graph for vaccination coverage in the age group of 18-25 years has been added to this week’s update.


Vaccination figures: 6 January – 22 August 2021

Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 33 (2021), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose7 Total
GGD 91+ 1930 and earlier 26 January 2021 68,119 66,304 134,423
GGD 86-90 1931-1935 29 January 2021 188,741 185,210 373,951
GGD 81-85 1936-1940 5 February 2021 376,084 369,977 746,061
GGD 76-80 1941-1945 6 March 2021 571,659 561,105 1,132,764
GGD 71-75 1946-1950 6 April 2021 857,059 831,658 1,688,717
GGD 66-70 1951-1955 19 April 2021 796,803 763,467 1,560,270
GGD 61-65 1956-1960   135,322 136,897 272,219
GGD 56-60 1961-1965 27 April 2021 1,014,679 937,184 1,951,863
GGD 51-55 1966-1970 20 May 2021 1,018,528 725,403 1,743,931
GGD 46-50 1971-1975 26 May 2021 864,316 763,301 1,627,617
GGD 41-45 1976-1980 29 May 2021 748,162 604,149 1,352,311
GGD 36-40 1981-1985 1 June 2021 707,652 596,004 1,303,656
GGD 31-35 1986-1990 7 June 2021 694,952 561,882 1,256,834
GGD 26-30 1991-1995 11 June 2021 670,142 505,562 1,175,704
GGD 18-25 1996-2003 15 June 2021 1,081,831 686,825 1,768,656
GGD 12-17 2004-2009 22 June 2021 561,747 268,403 830,150
GGD Unknown Unknown   2,525 1,846 4,371
GPs (estimated)3,4     15 February 2021 1,228,627 1,088,917 2,317,544
Other vaccinators (estimated)3,5     6 January 2021 925,625 488,375 1,414,000
Total6       12,512,573 10,142,469 22,655,042

Footnotes:

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen® . One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
  3. Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines will be administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
  5. For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).  From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  6. 206,682 estimated vaccinations administered by other vaccinators, and 578,547 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
  7. The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.

Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 33, 2021 

Age group Birth years Vaccination turnout Vaccination coverage
12 years and older 2009 and before 82.4% 72.0%
18 years and older 2003 and before 84.9% 75.7%

 Explanation:

  1. Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by birth year, Statistics Netherlands (CBS), January 2020.
  2. The turnout and vaccination coverage for 18 years and older reported here are also reported on the website of the European Centre for Disease Prevention and Control (ECDC).
  3. The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
  4. The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS is displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
  5. People who have been vaccinated by the GGD with the Janssen vaccine are included in both turnout and vaccination coverage, since this is a single-dose vaccine.
  6. Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
  7. People who have already had COVID-19 will only need one dose of COVID-19 vaccine. Since our dataset currently does not include sufficient data on this, however, for the time being these people will be counted among the group of people who have been fully vaccinated (except for those who received the Janssen vaccine).
  8. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated.
  9. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday. To calculate turnout and vaccination coverage in this table, the denominator is an estimate of the number of young people who will turn 12 years old in the current week.

17 August 2021 | 5:00 PM

Vaccination figures: 9– 15 August 2021

By Sunday 15 August, it is estimated that 22.3 million vaccinations had been administered in the Netherlands. More than 12.4 million of those were first vaccinations, and more than 9.9 million were second vaccinations. It is estimated that nearly 75% of all people over 18 have received full vaccination by now. About 85% have received their first vaccination. 

Turnout for first vaccination

The RIVM National Institute for Public Health and the Environment   vaccination update shows that turnout for a first vaccination is no longer increasing in most age groups. First vaccinations are still being added in each age group, but the number is small compared to the total. A minor increase can be observed in the youngest age groups. 46% of all young people born in 2004 through 2009 have now received their first vaccination. Young people born in 2009 who have not yet turned 12 cannot make an appointment yet. If they are not included in the calculations, then vaccination turnout in the 12-17 age group is currently 49%.  

Vaccination coverage

Vaccination coverage indicates which age groups have received two vaccinations or one Janssen vaccination. Vaccination coverage among young people has continued to increase. The age group of 12-17 years has achieved a vaccination coverage of 14%. Coverage is 15% if children born in 2009 who have not yet turned 12 are not included. For people aged 18-25 years, vaccination coverage has increased to 49%, rising to 52% for people aged 26-30. Vaccination coverage also increased somewhat in the age group of 30-39 years. Among people aged 40 years and older, vaccination coverage has stabilised or is still increasing slightly.

Vaccination coverage by municipality

Vaccination coverage by municipality is displayed according to people in various age groups who have received two vaccinations or one Janssen vaccination. In the age group of 26-45 years, vaccination coverage primarily increased in the east and southeast of the Netherlands and in the Randstad conurbation. The increase in these areas is also reflected in vaccination coverage among people aged 18 years and older.
 


Vaccination figures: 6 January – 15 August 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 32 (2021), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose Total
GGD 91+ 1930 and earlier 26 January 2021 68,089 66,246 134,335
GGD 86-90 1931-1935 29 January 2021 188,672 185,097 373,769
GGD 81-85 1936-1940 5 February 2021 375,906 369,756 745,662
GGD 76-80 1941-1945 6 March 2021 571,366 560,638 1,132,004
GGD 71-75 1946-1950 6 April 2021 856,610 830,827 1,687,437
GGD 66-70 1951-1955 19 April 2021 796,215 762,052 1,558,267
GGD 61-65 1956-1960   134,149 133,271 267,420
GGD 56-60 1961-1965 27 April 2021 1,013,072 934,077 1,947,149
GGD 51-55 1966-1970 20 May 2021 1,016,102 720,892 1,736,994
GGD 46-50 1971-1975 26 May 2021 861,340 757,520 1,618,860
GGD 41-45 1976-1980 29 May 2021 744,854 597,128 1,341,982
GGD 36-40 1981-1985 1 June 2021 702,983 584,925 1,287,908
GGD 31-35 1986-1990 7 June 2021 688,462 545,639 1,234,101
GGD 26-30 1991-1995 11 June 2021 663,199 485,128 1.148,327
GGD 18-25 1996-2003 15 June 2021 1,070,400 640,717 1,711,117
GGD 12-17 2004-2009 22 June 2021 532,599 165,636 698,235
GGD Unknown Unknown   2,434 1,767 4,201
GPs (estimated)4,5     15 February 2021 1,228,627 1,088,917 2,317,544
Other vaccinators (estimated)4,6     6 January 2021 925,625 488,108 1,413,733
Total7       12,440,704 9,918,341 22,359,045

Footnotes:

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 32, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen® . One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The Municipal Public Health Services (GGDs) vaccinates care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), young people living at home who were born in 2003-2005 and who are in medical high-risk groups (from 18 May 2021), and people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age). The start date in the table refers to the birth year. On the Wadden Islands, vaccination started from 16 February 2021 for people born in 1941-1945 on the islands of Texel, Terschelling and Ameland, and for people born in 1941-1960 for the islands of Vlieland and Schiermonnikoog. From 25 May 2021, vaccination on the Wadden Islands was available for all people born in 2003 or before. People born in 1956-1960 were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they were also able to make an appointment for vaccination with COM/SPX via the GGD. The people in this table who were born in 1956-1960 are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1953-1955 may also have been vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. This group could decide for themselves whether they accepted the invitation from their GP or were vaccinated by the GGD. Finally, people living in a residential institution are sometimes also vaccinated by the GGD. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before receiving the vaccine.  Young people born in July and August 2009 can make an appointment after their birthday; the strategy for September and beyond is not yet known.
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment   is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery).For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines will be administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
  5. For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).  From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  6. 206,682 estimated vaccinations administered by other vaccinators, and 574,932 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.

10 August 2021 | 17:30 PM

Vaccination figures: 2– 8 August 2021

By Sunday 8 August, it is estimated that 21.6 million vaccinations had been administered in the Netherlands. More than 12.3 million of those were first vaccinations, and more than 9.2 million were second vaccinations. It is estimated that more than 71% of all people over 18 have been fully vaccinated by now. Based on registered vaccinations, more than 84% of all people over 51 have been fully vaccinated, rising to 91% of all people aged 76-80 years.

Turnout among children, adolescents and young adults continues to rise

The 29th RIVM National Institute for Public Health and the Environment   vaccination update shows that vaccination turnout in the age group of 12-17 years has continued to increase. By week 31, more than 43% of all young people born in 2004 through 2009 had received their first vaccination. Some of the young people born in 2009 cannot make an appointment yet, because they have not turned 12 yet. If this group is not included in the calculations, then vaccination turnout in the 12-17 age group is currently 47%.  64% of young adults aged 18-25 have received a first vaccination. 

Vaccination turnout by municipality

The figure shows turnout by municipality among people aged 18 years and older who have received at least one vaccination. Regional differences in turnout are minor. In all age groups, vaccination turnout is slightly higher in the east and southeast of the country, and lower in several municipalities in the Dutch ‘Bible belt’ and in a few bigger cities.

Various corrections in the dataset

Several corrections have been made in the GGD GHOR dataset, and a correction has been made on the RIVM end ads well. For example, the heterologous vaccinations after AstraZeneca were not classified as first vaccinations but as second vaccinations, and cancelled appointments were removed from the GGD GHOR dataset. As a result, the number of vaccinations administered by the Municipal Public Health Services (GGDs) throughout the entire vaccination campaign was corrected on Friday 6 August. This involved approximately 160,000 vaccinations. This leads to minor changes in the figures for first and second vaccinations. Based on the updated dataset, over 84% of over-18s had received at least one vaccination by Sunday 8 August. 


Vaccination figures: 6 January – 8 August 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 31 (2021), by type of vaccinator.

Vaccinator Target group Birth year Start date2 First dose Second dose Total
GGD 91+ 1930 en eerder 26 January 2021 68,057 66,113 134,170
GGD 86-90 1931-1935 29 January 2021 188,600 184,853 373,453
GGD 81-85 1936-1940 5 February 2021 375,716 369,246 744,962
GGD 76-80 1941-1945 6 March 2021 571,112 559,520 1,130,632
GGD 71-75 1946-1950 6 April 2021 856,159 828,699 1,684,858
GGD 66-70 1951-1955 19 April 2021 795,547 759,110 1,554,657
GGD 61-65 1956-1960   132,921 125,112 258,033
GGD 56-60 1961-1965 27 April 2021 1,011,263 926,896 1,938,159
GGD 51-55 1966-1970 20 May 2021 1,013,472 709,106 1,722,578
GGD 46-50 1971-1975 26 May 2021 858,167 740,902 1,599,069
GGD 41-45 1976-1980 29 May 2021 741,450 576,268 1,317,718
GGD 36-40 1981-1985 1 June 2021 698,033 550,041 1,248,074
GGD 31-35 1986-1990 7 June 2021 681,111 488,483 1,169,594
GGD 26-30 1991-1995 11 June 2021 655,415 391,412 1,046,827
GGD 18-25 1996-2003 15 June 2021 1,058,635 366,233 1,424,868
GGD 12-17 2004-2009 22 June 2021 501,760 54,244 556,004
GGD Unknown Unknown   2,315 1,641 3,956
GPs (estimated)4,5     15 February 2021 1,228,627 1,088,917 2,317,544
Other vaccinators (estimated)4,6     6 January 2021 925,625 483,251 1,408,876
Total7       12,363,985 9,270,047 21,634,032

Footnotes:

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 31, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. 
  2. The Municipal Public Health Services (GGDs) vaccinates care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), young people living at home who were born in 2003-2005 and who are in medical high-risk groups (from 18 May 2021), and people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age). The start date in the table refers to the birth year. On the Wadden Islands, vaccination started from 16 February 2021 for people born in 1941-1945 on the islands of Texel, Terschelling and Ameland, and for people born in 1941-1960 for the islands of Vlieland and Schiermonnikoog. From 25 May 2021, vaccination on the Wadden Islands was available for all people born in 2003 or before. People born in 1956-1960 were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they were also able to make an appointment for vaccination with COM/SPX via the GGD. The people in this table who were born in 1956-1960 are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1953-1955 may also have been vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. This group could decide for themselves whether they accepted the invitation from their GP or were vaccinated by the GGD. Finally, people living in a residential institution are sometimes also vaccinated by the GGD. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before receiving the vaccine.  Young people born in July and August 2009 can make an appointment after their birthday; the strategy for September and beyond is not yet known.
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment   is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery).For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines will be administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
  5. For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).  From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  6. 206,682 estimated vaccinations administered by other vaccinators, and 570,335 vaccinations administered by the GGD, involved JANSS.These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.

4 August 2021 | 12:40 PM

Vaccination figures: 6 January – 3 August 2021

Read the news: Nearly 85% of people aged 18 and over have had at least one vaccination

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 30 (2021), by type of vaccinator.

Vaccinator Target group Birth year Start date First dose Second dose Total
GGD 91+ 1930 and before 26 January 2021 68,467 66,007 134,474
GGD 86-90 1931-1935 29 January 2021 189,653 184,756 374,409
GGD 81-85 1936-1940 5 February 2021 377,546 368,854 746,400
GGD 76-80 1941-1945 6 March 2021 574,250 558,204 1,132,454
GGD 71-75 1946-1950 6 April 2021 861,649 826,667 1,688,316
GGD 66-70 1951-1955 19 April 2021 802,114 756,009 1,558,123
GGD 61-65 1956-1960   154,943 94,843 249,786
GGD 56-60 1961-1965 27 April 2021 1,026,950 924,052 1,951,002
GGD 51-55 1966-1970 20 May 2021 1,024,370 697,107 1,721,477
GGD 46-50 1971-1975 26 May 2021 869,515 720,141 1,589,656
GGD 41-45 1976-1980 29 May 2021 748,325 541,554 1,289,879
GGD 36-40 1981-1985 1 June 2021 702,005 472,974 1,174,979
GGD 31-35 1986-1990 7 June 2021 679,484 332,499 1,011,983
GGD 26-30 1991-1995 11 June 2021 648,597 189,851 838,448
GGD 18-25 1996-2003 15 June 2021 1,051,459 219,439 1,270,898
GGD 12-17 2004-2009 22 June 2021 462,014 17,748 479,762
GGD Age unknown birth year unknown   2,461 1,613 4,074
GPs     15 February 2021 1,228,627 1,088,917 2,317,544
Other vaccinators     6 January 2021 925,625 482,411 1,408,036
Total       12,398,054 8,543,646 20,941,700

Footnotes:

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 30, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. 
  2. The Municipal Public Health Services (GGDs) vaccinate people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people living at home who were born in 2003-2005 (aged 16-18 years at that time). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 for people born in 1941-1945 (aged 75-79 years at that time) on the islands of Texel, Terschelling and Ameland, and for people born in 1941-1960 (aged 60-79 years at that time) for the islands of Vlieland and Schiermonnikoog). From 25 May 2021, vaccination on the Wadden Islands was available for all people born in 2003 or before (aged 18 years and over at that time). People born in 1956-1960 (aged 60-64 years at that time) were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they were also able to make an appointment for vaccination with COM/SPX via the GGD. The people in this table who were born in 1956-1960 (aged 60-64 years at that time) are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years at that time) also had the option to be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960 (aged 60-64 years at that time). This group could decide for themselves whether they accepted the invitation from their GP or were vaccinated by the GGD. Finally, people living in a residential institution are sometimes also vaccinated by the GGD. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before receiving the vaccine. Young people born in July and August 2009 can make an appointment after their birthday; the strategy for September and beyond is not yet known.
  3. From 16 July 2021 on, people who have been vaccinated with VAX as a first dose will have the opportunity to be vaccinated with COM by the GGD for their second dose. This mainly involves people born in 1956-1960 (aged 61-65 years). As long as these vaccinations are not yet recognisable as a second dose in the data, they will be counted as in the category of the first dose. This applies to all second doses administered by the GGD if the first vaccination was administered by a vaccinator other than the GGD.
  4. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  5. Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines will be administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
  6. For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  7. 206,682 estimated vaccinations administered by other vaccinators, and 561,728 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.

27 July 2021 | 16:20 PM

Vaccination figures: 19 to 25 July 2021

By Sunday 25 July, it is estimated that more than 20.1 million vaccinations had been administered in the Netherlands. More than 12.2 million of those were first vaccinations, and nearly 8 million were second vaccinations. In the age group of 30-39 years, more than 1.4 million people have now received their first vaccination. More than 80% of all people over 50 have been fully vaccinated, rising to 88% of all people aged 80-89 years.

Turnout among young people aged 12-17 years continues to rise

The 27th RIVMNational Institute for Public Health and the Environment vaccination update shows that vaccination turnout in the age group of 12-17 years has continued to increase. By week 29, 482,186 young people (41%) in this group had received their first vaccination from the Municipal Public Health Services (GGDs).

Geographic distribution

Looking at the Netherlands, vaccination turnout has been higher among various age groups in the east and south of the country, with the exception of the province of Zeeland, than in other parts of the country. This trend has been observed both among people over 65 who are now fully vaccinated, and among people aged 45-64 years. The same trend seems to be emerging cautiously among people aged 25-44 years.

This is not entirely new information. National figures for vaccination turnout in the context of the National Immunisation Programme show a similar geographic distribution. In that context as well, vaccination turnout is higher in the east and southeast of the country, and lower in municipalities in the Dutch ‘Bible belt’ and in a few bigger cities.

Vaccination coverage still rising

Vaccination coverage among people aged 70 years and older is increasing very slowly at this point; most people in these age groups have already been fully vaccinated. 90% of people aged 70-79 years are now fully vaccinated. In the younger age groups, vaccination coverage is still increasing every week. In the past week, vaccination coverage increased to 65% among people aged 45-49 years and 56% among people aged 40-44 years.

Vaccination figures: 6 January – 25 July 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 29 (2021), by type of vaccinator.

Vaccinator Target group Start date2 First dose3 Second dose Totaal
GGD People aged 90 and up 26 January 2021 68, 451 65,844 134,295
GGD 85-89 years 29 January 2021 189,615 184,643 374,258
GGD 80-84 years 5 February 2021 377,492 368,607 746,099
GGD 75-79 years 6 March 2021 574,353 557,760 1,132,113
GGD 70-74 years 6 April 2021 862,491 826,466 1,688,957
GGD 65-69 years 19 April 2021 803,526 755,797 1,559,323
GGD 60-64 years   148,498 76,851 225,349
GGD 55-59 years 27 April 2021 1,026,103 916,302 1,942,405
GGD 50-54 years 20 May 2021 1,021,180 668,444 1,689,624
GGD 45-49 years 26 May 2021 865,719 673,519 1,539,238
GGD 40-44 years 29 May 2021 742,590 466,714 1,209,304
GGD 35-39 years 1 June 2021 690,917 307,481 998,398
GGD 30-34 years 7 June 2021 664,068 158,740 822.808
GGD 25-29 years 11 June 2021 634,295 123,181 757,476
GGD 18-24 years 15 June 2021 903,180 163,743 1,066,923
GGD 12-17 years 22 June 2021 482,186 15,574 497,760
GGD Age unknown   22.650 1.292 23.942
GPs (estimated)4,5   15 February 2021 1,228,627 1,088,917 2,317,544
Other vaccinators (estimated)4,6   6 January 2021 925,625 477,990 1,403,615
Total7     12,231,566 7,897,865 20,129,431

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 29, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. 
  2. The Municipal Public Health Services (GGDs) vaccinate people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they can also make an appointment for vaccination with COM/SPX via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
  3. From 16 July 2021 on, people who have been vaccinated with VAX as a first dose will have the opportunity to be vaccinated with COM by the GGD for their second dose. This mainly involves people aged 60-64 years. As long as these vaccinations are not yet recognisable as a second dose in the data, they will be counted as in the category of the first dose. This applies to all second doses administered by the GGD if the first vaccination was administered by a vaccinator other than the GGD.
  4. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  5. Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines will be administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
  6. For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  7. 206,682 estimated vaccinations administered by other vaccinators, and 554,260 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.

20 July 2021 | 16:35 PM

Vaccination figures: 6 January – 18 July 2021

Read the news: Vaccination turnout for people aged 25-44: 66% vaccinated at least once

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 28 (2021), by type of vaccinator.

Vaccinator Target group Start date2 First dose3 Second dose Totaal
GGD People aged 90 and up 26 January 2021 68,094 65,458 133,552
GGD 85-89 years 29 January 2021 188,727 183,719 372.446
GGD 80-84 years 5 February 2021 375,784 366,866 742,650
GGD 75-79 years 6 March 2021 571,210 554,740 1,125,950
GGD 70-74 years 6 April 2021 855,872 820,341 1,676,213
GGD 65-69 years 19 April 2021 794,377 746,750 1,541,127
GGD 60-64 years   136,930 65,793 202,723
GGD 55-59 years 27 April 2021 1,005,134 881,468 1,886,602
GGD 50-54 years 20 May 2021 996,038 567,120 1,563,158
GGD 45-49 years 26 May 2021 836,359 497,470 1,333,829
GGD 40-44 years 29 May 2021 727,570 297,942 1,025,512
GGD 35-39 years 1 June 2021 678,308 178.141 856,449
GGD 30-34 years 7 June 2021 652,329 113,775 766,104
GGD 25-29 years 11 June 2021 622,659 100,144 722,803
GGD 18-24 years 15 June 2021 880,580 144,955 1,025,535
GGD 12-17 years 22 June 2021 376,238 13,114 389,352
GGD Age unknown   10,868 892 11,760
GPs (estimated)4,5   15 February 2021 1,228,627 1,088,917 2,317,544
Other vaccinators (estimated)4,6   6 January 2021 925,607 476,251 1,401,858
Total7     11,931,311 7,163,856 19,095,167

Footnotes:

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 28, 2021, by type of vaccinator.

 COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient. 

  1. The Municipal Public Health Services (GGDs) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they can also make an appointment for vaccination with COM/SPX via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
  2. From 16 July 2021 on, people who have been vaccinated with VAX as a first dose will have the opportunity to be vaccinated with COM by the GGD for their second dose. As long as these vaccinations are not yet recognisable as a second dose in the data, they will be counted as a first dose, which is the case if the first vaccination was administered by a vaccinator other than the GGD.
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment   is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. It is assumed that no more vaccines will be administered by GPs after 7 July 2021.
  5. For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  6. 206,664 estimated vaccinations administered by other vaccinators, and 546,414 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.

13 July 2021 | 17:00 PM

Vaccination figures: 6 January – 11 July 2021

Read the news: Vaccination coverage is rising, while data is increasingly comprehensive

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 27 (2021), by type of vaccinator.

Vaccinator Target group Start date2 First dose Second dose Total
GGD
  • People aged 90 and up
26 January 2021 68,041 64,539 132,580
GGD
  • 85-89 years
29 January 2021 188,628 181,265 369,893
GGD
  • 80-84 years
05 February 2021 375,620 362,206 737,826
GGD
  • 75-79 years
06 March 2021 570,864 546,431 1,117,295
GGD
  • 70-74 years
06 April 2021 855,265 802,284 1,657,549
GGD
  • 65-69 years
19 April 2021 792,928 722,239 1,515,167
GGD
  • 60-64 years
  126,414 60,175 186,589
GGD
  • 60-64 years
27 April 2021 1,002,245 754,446 1,756,691
GGD
  • 50-54-years
20 May 2021 991,443 367,37 1,358,822
GGD
  • ​​45-49-years
26 May 2021 830,760 249,527 1,080,287
GGD
  • 40-44-years
29 May 2021 721,140 145,385 866,525
GGD
  • 35-39-years
01 June 2021 668,766 105,590 774,356
GGD
  • 30-34-years
07 June 2021 637,822 90,119 727,941
GGD
  • 25-29-years
11 June 2021 603,987 84,801 688,788
GGD
  • 18-24-years
18 June 2021 844,123 126,239 970,362
GGD
  • 12-17-years
22 June 2021 256,779 10.260 267,039
GGD

Age unknown

  4,717 579 43,4343
GPs (estimated)4,5   15 February 2021 1,228,627 1,089,034 2,317,670
Other vaccinators (estimated)4,6   06 January 2021  925,580 465,738 1,391,318
Total7     11,693,749 6,228,245 17,960,1323

Footnotes:

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine, weeks 1 through 27, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna®); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The Municipal Public Health Services (GGDs) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they can also make an appointment for vaccination with COM/MOD via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
  3. Due to incomplete transmission of vaccination data by GGD GHOR in CoronIT, some of the vaccinations administered by the GGD in weeks 23-25 of 2021 have been estimated based on the number of registered vaccination appointments, taking into account an average number of appointments that did not take place as planned.  In total, this involves an estimated 38,138 vaccinations that have temporarily been registered as ‘age unknown’, with no distinction made between the first and second dose. For that reason, these vaccinations are only displayed in the ‘Total’ column, not in under ‘First dose’ and ‘Second dose’.
  4. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  5. Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses. As of 07 July 2021, it is assumed that the estimated number of vaccinations by general practitioners will not increase, even though vaccines may still be administered in the practice.
  6. For VAX, the same assumption is used as for vaccinations by general practitioners (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  7. 206,637 estimated vaccinations administered by other vaccinators, and 532,289 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ column, since 1 dose of this vaccine is sufficient

06 July 2021 | 17:00 PM

Vaccination figures: 28 June – 4 July 2021

By Sunday 4 July, it is estimated that more than 16.7 million vaccinations had been administered in the Netherlands. More than 10.8 million of those were first vaccinations, and over 5.8 million were second vaccinations. The daily number of vaccinations administered is posted on the Coronavirus Dashboard.

First vaccination

Among people over 65, turnout for a first vaccination is high: 92%. Turnout for a first vaccination is rising steadily among the under-60 age groups. People aged 50-54 and 55-59 years have reached a turnout of 81% and 85% so far, while people aged 40-44 and 45-59 years are at 72% and 76%. Vaccination turnout is at 55% and 64% for people aged 30-34 and 35-39 years, and people aged 20-24 and 25-29 years have now reached 38% and 47%. The age group of 17-19 years has reached 29% for a first vaccination. The youngest age group of 12-16 years has been included in this report for the first time; they have been able to make an appointment since last Friday. Young people aged 12-17 years with a medical indication were able to make an appointment earlier. Vaccination turnout for the age group of 12-16 years is now at 2%.

Vaccination turnout by municipality

The figure shows turnout by municipality among people over 65 years old and people between 45 and 64 who have received at least one vaccination. In almost all municipalities, turnout among over-65s is at least 85%. Turnout for people between 45 and 64 years old is above 75% in most municipalities and above 85% in many municipalities. These age groups have continued to show rising vaccination figures over the past few weeks.

Vaccination coverage is increasing

Vaccination coverage indicates what percentage of the population has been fully vaccinated. This applies to people who have received two vaccinations, or one vaccination with the Janssen vaccine. People who have received one vaccination after previously having had COVID-19 are not yet counted as fully vaccinated in this update, because the data is not yet complete.

72% of all adults living in the Netherlands have now received at least their first vaccination, and at least 41% are fully vaccinated. This data is based on registered vaccinations in the national vaccination system.

Vaccination coverage among people over 65 has reached 84%. More and more people between 50 and 60 years old are fully vaccinated: 57% of people aged 55-59 and 41% of people aged 50-54. In the next few weeks, vaccination coverage will continue to rise.

Vaccination coverage among people aged 50-54 rose more quickly in the first few weeks after this age group was eligible, compared to recent weeks. This can be explained by the fact that some of the people in this age group (born in 1967 and 1968) were given the Janssen vaccine. These people count as fully vaccinated after one vaccination. People from other birth years within this age group still need a second vaccination before they are fully vaccinated.

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 26 (2021), by type of vaccinator.

Uitvoerder Doelgroep Startdatum2 Eerste dosis Tweede dosis Totaal4
GGD
  • People aged 90 and up
26 January 2021 67,918 64,457 132,375
GGD
  • 85-89 years
29 January 2021 188,380 181,043 369,423
GGD
  • 80-84 years
05 February 2021 375,086 361,632 736,718
GGD
  • 75-79 years
06 March 2021 569,649 545,525 1,115,174
GGD
  • 70-74 years
06 April 2021 853,013 800,241 1,653,254
GGD
  • 65-69 years
19 April 2021 789,732 718,385 1,508,117
GGD
  • 60-64 years
  116,856 58,909 175,765
GGD
  • 60-64 years
27 April 2021 993,945 653,597 1,647,542
GGD
  • 50-54-years
20 May 2021 976,784 263,947 1,240,731
GGD
  • ​​45-49-years
26 May 2021 810,607 165,209 975,816
GGD
  • 40-44-years
29 May 2021 695,802 115,087 810,889
GGD
  • 35-39-years
01 June 2021 628,691 91,265 719,956
GGD
  • 30-34-years
07 June 2021 572,562 80,934 653,496
GGD
  • 25-29-years
11 June 2021 490,166 76,324 566,490
GGD
  • 20-24-years
15 June 2021 383,883 82,543 466,426
GGD
  • 17-19-years
18 June 2021 172,834 39,390 212,224
GGD
  • 12-16-years
22 June 2021 18,985 455 19,440
GGD

Age unknows

  1,756 376 40,2703
GPs (estimated)4,5   15 February 2021 1,228,643 1,068,688 2,297,331
Other vaccinators (estimated)4,6   06 January 2021 925,580 459,707 1,385,287
Total7     10,860,872 5,827,714 16,726,7243

Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine, weeks 1 through 26, 2021, by type of vaccinator.

  1. COM = Comirnaty® (Pfizer/BioNTech); MOD = Spikevax® (formerly COVID-19 Vaccine Moderna®); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The Municipal Public Health Services (GGDs) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they can also make an appointment for vaccination with COM/MOD via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
  3. Due to incomplete transmission of vaccination data by GGD GHOR in CoronIT, some of the vaccinations administered by the GGD in week 23-25 of 2021 have been estimated based on the number of registered vaccination appointments, taking into account an average number of appointments that did not take place as planned.  In total, this involves an estimated 38,138 vaccinations that have temporarily been registered as ‘age unknown’, with no distinction made between the first and second dose. For that reason, these vaccinations are only displayed in the ‘Total’ column, not in under ‘First dose’ and ‘Second dose’.
  4. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for MOD, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  5. Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
  6. For VAX, the same assumption is used as for vaccinations by general practitioners (see above). For MOD, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  7. 206,637 estimated vaccinations administered by other vaccinators, and 462,641 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ column, since 1 dose of this vaccine is sufficient

22 June 2021 | 16:00 PM

Vaccination figures: 14 to 20 June 2021

By Sunday 20 June, it is estimated that nearly 13.9 million vaccinations had been administered in the Netherlands. More than 8.6 million of those were first vaccinations, and 4.4 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.

Vaccination turnout is high

Vaccination turnout among all age groups is high or has increased significantly. Turnout has been high in the age groups over 65: between 84% and 92% for the first vaccination.

People aged 55-59 years have reached a turnout of 81% so far, while people aged 50-54 years are at 71% for the first vaccination. Turnout for people aged 45-49 and 40-44 has risen to 60% and 48% respectively.

The age groups that were invited most recently are showing an increase in turnout: the 35-39 age group is at 27%, the 30-34 age group is at 16%, and turnout among people aged 25-29 years is at 14%.

Vaccination turnout by municipality

The figure shows turnout by municipality among people over 65 years old who have received at least one vaccination. Regional differences in turnout are minimal. Most municipalities have seen a turnout of at least 85%. A figure showing turnout among people under 65 is expected to be published next week.

Vaccination coverage is increasing

Vaccination coverage indicates what percentage of the population has been fully vaccinated. This applies to people who have received two vaccinations with Pfizer, Moderna or AstraZeneca, or one vaccination with Janssen. People who have received one vaccination after previously having had COVID-19 are also fully vaccinated. This final group is still counted among the group that has received one vaccination. In the data supplied to RIVMNational Institute for Public Health and the Environment , it is not yet possible to separate the number of people who have received one vaccination after having had COVID-19 from other people who have received one vaccination.

Vaccination coverage among people over 65 has increased and now ranges from over 65% to nearly 87%. Many age groups under 65 years old will be receiving their second vaccination in the next few weeks. Vaccination coverage will continue to increase as the vaccination programme progresses.

Data
Vaccination turnout is calculated on the basis of data from the Municipal Public Health Services (GGDs) and from other vaccinators, such as GPs, hospitals and care institutions. Data from other vaccinators comes from the national registration system (CIMS). RIVM has not yet received all the data. As a result, the vaccination records are not yet complete and the actual turnout is somewhat higher.

Technical malfunction at the GGD
Due to a technical malfunction at the GGD GHOR, a number of vaccinations on a number of days over the past two weeks were not fully reported to RIVM. Therefore, an estimate was provided based on the number of appointments scheduled on those days. This involves approximately 840,000 vaccinations. With this estimate, it is not possible to make a distinction according to age or first and second dose. For that reason, the 840,000 vaccinations have only been counted in the total number of vaccinations. The GGD is working to resolve the technical malfunction.

Vaccination figures 6 January to 13 June 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 24 (2021), by type of vaccinator.

Vaccinator Target group Start date2 First dose Second dose Total
GGD
  • People aged 90 and up
26 January 2021    67,414 63,874 131,288
GGD
  • 85-89 years
29 January 2021   187,792 179,358 367,150
GGD
  • 80-84 years
05 February 2021   373,753 357,555 731,308
GGD
  • 75-79 years
06 March 2021   566,477 539,413 1,105,890
GGD
  • 70-74 years
06 April 2021   848,286 779,227 1,627,513
GGD
  • 65-69 years
19 April 2021   782,299 620,747 1,403,046
GGD
  • 60-64 years
     74,529 54,100 128,629
GGD
  • 55-59 years
27 April 2021   952,394 231,470 1,183,864
GGD
  • 50 -54 years
20 May 2021   860,990 84,534 945,524
GGD
  • 45 - 49 years
26 May 2021    628,273 60,997 689,270
GGD
  • 40 - 44 years
29 May 2021    459,110 46,085 505,195
GGD
  • 35 - 39 years
1 June 2021    248,200 38,342 286,542
GGD
  • 30 - 34 years
7 June 2021    140,047 35,655 175,702
GGD
  • 25 - 29 years
11 June 2021    118,114 34,497 152,611
GGD
  • 20 - 24 years
15 June 2021   118,301 40,858 159,159
GGD
  • <20 years
18 June 2021     59,841 17,395 77,236
GGD
  • Age unknown
        1,194      339 841,9443
Vaccinated by GPs (estimated)4,5   15 February 2021 1,228,660 755,904 1,984,564
Vaccinated by other vaccinators (estimated)4,6   06 January 2021    906,753 471,976 1,378,729
Total7     8,622,427 4,412,326 13,875,1643

Voetnoten:

  1. COM = Comirnaty® (Pfizer/BioNTech); MOD = COVID-19 Vaccine Moderna®; VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The Municipal Public Health Service (GGD) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they can also make an appointment for vaccination with COM/MOD via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
  3. Due to incomplete transmission of vaccination data by GGD GHOR in CoronIT, some of the vaccinations administered by the GGD in weeks 23-24  of 2021 have been estimated based on the number of registered vaccination appointments, taking into account an average number of appointments that did not take place as planned. In total, this involves an estimated 840,411 vaccinations that have temporarily been registered as ‘age unknown’, with no distinction made between the first and second dose. For that reason, these vaccinations are only displayed in the ‘Total’ column, not in under ‘First dose’ and ‘Second dose’.
  4. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered by GPs within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for MOD, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  5. Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
  6. For VAX, the same assumption is used as for vaccinations by general practitioners (see above). For MOD, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).  From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  7. 190,762 estimated vaccinations administered by other vaccinators, and 259,183 vaccinations administered by the GGD, involved JANSS. This vaccinations are only displayed in the ‘First dose’ column, since 1 dose of this vaccine is sufficient.

15 June 2021 | 16:15 PM

Vaccination figures: 7 to 13 June 2021

By Sunday 13 June, it is estimated that more than 12.4 million vaccinations had been administered in the Netherlands. Almost 8.3 million of those were first vaccinations, and 4 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.

Vaccination turnout is high

Vaccination turnout among all age groups is high or has increased significantly. Turnout has been high in the age groups over 65: between 83% and 92% for the first vaccination. People aged 55-59 years have reached a turnout of 80% so far, while people aged 50-54 years are at 68% for the first vaccination. Vaccination turnout for people aged 45-49 and 40-44 has risen to 51% and 41% respectively, and people aged 35-39 years are at 22%. The age groups of 30-34 years and 25-29 years have been added, and have reached a turnout of 14% and 13% for the first vaccination.

Vaccination turnout by municipality

The figure shows turnout by municipality among people over 65 years old who have received at least one vaccination. Regional differences in turnout are minimal. Most municipalities have seen a turnout of at least 85%.

Vaccination coverage is increasing

Vaccination coverage indicates what percentage of the population has been fully vaccinated. This applies to people who have received one vaccination with the Janssen vaccine or two vaccinations with another COVID-19 vaccine. Data is not yet available on people who have received one vaccination after previously having had COVID-19.

Vaccination coverage among people over 65 is now between 58% and 86%. A number of the over-65 age groups where vaccination coverage is not very high yet are still scheduled to receive a second vaccination. The same applies to most people under 60. Vaccination coverage will continue to increase as the vaccination programme progresses.

Data
Vaccination turnout is calculated on the basis of data from the Municipal Public Health Services (GGDs) and from other vaccinators, such as GPs, hospitals and care institutions. Data from other vaccinators comes from the national registration system (CIMS). RIVM National Institute for Public Health and the Environment   has not yet received all the data. As a result, the vaccination records are not yet complete and the actual turnout is somewhat higher.

Technical malfunction at the GGD
Due to a technical malfunction at GGD GHOR, a number of vaccinations on a number of days were not fully reported to RIVM. All the vaccinations that were administered have been registered by the Municipal Public Health Services (GGDs). An estimate was made based on the number of appointments scheduled on those days. This involves approximately 137,000 vaccinations. Based on this estimate, it was not possible to make a distinction according to age or first and second dose. For that reason, the 137,000 vaccinations have only been counted in the total number of vaccinations. GGD GHOR is working to resolve the technical malfunction. These vaccinations are expected to be fully processed and incorporated into the next weekly update.

Vaccination figures 6 January to 13 June 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1,  week 1 to week 23 (2021), by type of vaccinator.

Vaccinator Target group Start date2 First dose Second dose Total
GGD
  • People aged 90 and up
26 January 2021    67,371 63,682 131,053
GGD
  • 85-89 years
29 January 2021   187,692 178,686 366,378
GGD
  • 80-84 years
05 February 2021   373,525 356,208 729,733
GGD
  • 75-79 years
06 March 2021   566,025 537,346 1,103,371
GGD
  • 70-74 years
06 April 2021   847,571 770,343 1,617,914
GGD
  • 65-69 years
19 April 2021   780,571 556,888 1,337,787
GGD
  • 60-64 years
     71,075 52.308 123,383
GGD
  • 55-59 years
27 April 2021   942,324 151,859 1,094,183
GGD
  • 50 -54 years
20 May 2021   816,512 70,902 887,414
GGD
  • 45 - 49 years
26 May 2021    537,788 51,596 589,384
GGD
  • 40 - 44 years
29 May 2021    381,997 39,259 421,256
GGD
  • 35 - 39 years
1 June 2021    193,934 32,820 226,754
GGD
  • 30 - 34 years
7 June 2021    122,654 30,814 153,468
GGD
  • 25 - 29 years
11 June 2021     109,098 30,145 139,243
GGD
  • 20 - 24 years
     114,731 36,327 151,058
GGD
  • <20 years
      58,260 15,251 73,511
GGD
  • Age unknown
        1,134 312 138,5333
Vaccinated by GPs (estimated)4,5   15 February 2021 1,228,637 610,185 1,838,822
Vaccinated by other vaccinators (estimated)4,6   06 January 2021   884,441 434,660 1,319,101
Total7     8,285,668 4,019,591 12,442,3463

 

  1. COM = Comirnaty® (Pfizer/BioNTech); MOD = COVID-19 Vaccine Moderna®; VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
  2. The Municipal Public Health Service (GGD) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they can also make an appointment for vaccination with COM/MOD via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
  3. Due to a technical malfunction in the vaccination data registration by GGD GHOR in CoronIT, some of the vaccinations administered by the GGD in week 23 of 2021 have been estimated based on the number of registered vaccination appointments, taking into account an average number of appointments that did not take place as planned. In total, this involves an estimated 137,087 vaccinations that have temporarily been registered as ‘age unknown’, with no distinction made between the first and second dose. For that reason, these vaccinations are only displayed in the ‘Total’ column, not in under ‘First dose’ and ‘Second dose’.
  4. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment   is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered by GPs within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for MOD, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  5. Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
  6. For VAX, the same assumption is used as for vaccinations by general practitioners (see above). For MOD, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).        From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
  7. 172,542 estimated vaccinations administered by other vaccinators, and 258,536 vaccinations administered by the GGD, involved JANSS. This vaccinations are only displayed in the ‘First dose’ column, since 1 dose of this vaccine is sufficient.

8 June 2021 | 16:50 PM

Vaccination figures: 31 May to 6 June 2021

By Sunday 6 June, it is estimated that more than 10.7 million vaccinations had been administered in the Netherlands. More than 7.3 million of those were first vaccinations, and 3.4 million were second vaccinations.  The daily number of doses administered is posted on the Coronavirus Dashboard.

Vaccination turnout by age group

More than 50% of people over the age of 18 have received a first vaccination. Vaccination turnout in people over 65 is between 83% and 93% for the first vaccination. Turnout among people under 60 is rising quickly as the campaign moves forward. Turnout for the first vaccination has now reached 71% for people aged 55-59 and 50% for people aged 50-54. Vaccination turnout for people aged 45-49 and 40-45 is now at 29% and 23%. 14% of people aged 35-39 years have now received a first vaccination.

Vaccination turnout by municipality

The figures for vaccination turnout by municipality among people over 65 years old clearly show that regional differences have grown even smaller. The number of municipalities with a turnout higher than 85% among people over 65 has continued to increase.

Data
Vaccination turnout is calculated on the basis of data from the Municipal Public Health Services (GGDs) and from other vaccinators, such as GPs, hospitals and care institutions. Data from other vaccinators comes from the national registration system (CIMS). The data from those sources registered in CIMS is not yet complete. As a result, the actual turnout is somewhat higher.

Vaccinations with the Janssen vaccine are included in the vaccination reports from GGDGHOR as of this week. A technical change in the GGDGHOR reporting process had to be implemented to make that possible. In implementing that change, it became apparent that people who received only one vaccination after a previous COVID-19 infection had only been partially included in the figures reported by GGDGHOR and RIVM. That oversight has been corrected, bringing the number of vaccinations reported by RIVM to nearly 160,000 more vaccinations than last week.

Vaccination figures 6 January to 6 June 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 22 (2021), by type of vaccinator.

Vaccinator Target group Start date1 First dose Second dose Total
GGD
  • People aged 90 and up
26 January 2021    68,156    63,434 131,590
GGD
  • 85-89 years
29 January 2021   189,904 177,652 367,556
GGD
  • 80-84 years
05 February 2021   377,326 354,659 731,985
GGD
  • 75-79 years
06 March 2021   571,939 532,996 1,104,935
GGD
  • 70-74 years
06 April 2021   858,675 735,629 1,594,304
GGD
  • 65-69 years
19 April 2021   775,989 341,508 1,117,497
GGD
  • 60-64 years
     65,740 48,069 113,809
GGD
  • 55-59 years
27 April 2021   826,332 73,505 899,837
GGD
  • 50 -54 years
20 May 2021   592,507 59.243 651,750
GGD
  • 45 - 49 years
26 May 2021    282,177 43,057 325,234
GGD
  • 40 - 44 years
29 May 2021    197,608 32,760 230,368
GGD
  • 35 - 39 years
     118,021 27,529 145,550
GGD
  • 30 - 34 years
     101,190  25,826 127,016
GGD
  • 25 - 29 years
      95,323  25,538 120,861
GGD
  • 20 - 24 years
     102,496   31,115 133,611
GGD
  • <20 years
      50,631 13,243 63,874
GGD
  • Age unknown
             976       263    1.239
Vaccinated by GPs (estimated)2,3   15 February 2021 1,228,601 432,044 1,660,645
Vaccinated by other vaccinators (estimated)   06 January 2021   869,315 383,740 1,253,055
Total     7,372,906 3,401,810 10,774,716

Footnote table:

COM = Comirnaty® (Pfizer/BioNTech); MOD = COVID-19 Vaccine Moderna®; VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.

1 The Municipal Public Health Services (GGDs) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June on, they can also make an appointment for vaccination with COM/MOD via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.

2 A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for MOD, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.

3 Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.

4 For VAX, the same assumption is used as for vaccinations by general practitioners (see footnote 3). For MOD, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).   From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.

5 166,141 estimated vaccinations administered by other vaccinators, and 217,994 vaccinations administered by the GGD, involved JANSS. This involves the first dose, since 1 dose of this vaccine is sufficient.


1 June 2021 | 16:50 PM

Vaccination figures: 24 to 30 May 2021

By Sunday 30 May, it is estimated that more than 9.3 million vaccinations had been administered in the Netherlands. More than 6.5 million of those were first vaccinations, and 2.8 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard. The actual number of doses administered is about 78,000 higher than presented in the current overview. This is due to the data registered by the Municipal Public Health Services (GGDs) regarding the Janssen vaccine, which has been rolled out for vaccination since 28 May; this data has not yet been processed.

Vaccination turnout
As of this week, turnout will no longer be calculated solely on the basis of GGD data, but will also be supplemented with data from other vaccinators, such as GPs, hospitals and care institutions. Data from other vaccinators comes from the national registration system (CIMS). The data from those sources registered in CIMS is not yet complete; this applies in particular to people aged 60-64 years who are vaccinated by their GP. As a result, the actual turnout is likely to be somewhat higher. 

Vaccination turnout among people over 65 varies somewhat per age group, ranging from 82% to 92% for the first vaccination. Turnout for the first vaccination has now reached 59% for people aged 50-54 and 25% for people aged 50-54. On average, 87% of people aged 65 years and older have now had their first vaccination. RIVM published figures on vaccination turnout last Friday.

Turnout per municipality

Regional differences are minimal. Turnout in most municipalities is above 75%, and frequently higher than 85%.

 

Vaccination figures 6 January to 30 May 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 21 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Age groups (including healthcare workers) vaccinated by GGD2   COM/AZ/MOD      
  • People aged 90 and up
26 January 2021      67,905    62,934 130,839
  • 85-89 years
29 January 2021     189,202 176,321 365,523
  • 80-84 years
05 February 2021     375,683 352,054 727,737
  • 75-79 years
06 March 2021     567,149 522,095 1,089,244
  • 70-74 years
06 April 2021     828,936 564,086 1,393,022
  • 65-69 years
19 April 2021     728,180 120,218 848,461
  • 60-64 years
       63,461 47,051 110,512
  • 55-59 years
27 April 2021     678,160 60,859 739,019
  • 50 -54 years
20 May 2021     279,132 52,675 313,807
  • 45 - 49 years
26 May 2021      175,291 38,122 213,413
  • 40 - 44 years
29 May 2021      121,894 28,975 150,869
  • 35 - 39 years
       97,225 24,409 121,634
  • 30 - 34 years
       86,961 23,038 109,999
  • 25 - 29 years
       81,829 23,146 104,975
  • 20 - 24 years
       87,838 28,663 116,501
  • <20 years
       41,950 12,210 54,160
  • Age unknown
            868      202      1,070
Vaccinated by GPs (estimated)3,4 15 February 2021 AZ 1,228,601  300,383 1,528,984
Vaccinated by other vaccinators (estimated)3,5,6 06 January 2021 COM/MOD/AZ/JANSS   851,812  367,570 1,219,382
Total     6,552,077 2,805,074 9,357,151

Footnote table:

  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
  2. The Municipal Public Health Services (GGDs) vaccinates people living at home who are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups), care workers (from 6 January 2021 on), people who would normally be eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the first group. On the Wadden Islands, vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years will primarily be vaccinated with the AstraZeneca vaccine via their GP.  The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.  The vaccinations administered with the Janssen vaccine have not yet been included in these figures. This involves about 26,000 vaccinations a day. The Municipal Public Health Services (GGDs) started administering the Janssen vaccine on 28 May 2021. This means that the figures for the vaccinations administered by the GGD are underreported by about 78,000 vaccinations.
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of AZ will be administered from week 18 on; based on the rollout schedule for AZ and the number of inhabitants per province, the distribution of AZ vaccinations administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
  5. 156,277 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
  6. For AZ, the same assumption is used as for vaccinations by general practitioners (see footnote 4). For MOD, all second doses are assumed to have been given exactly 4 weeks after the first dose. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, deliveries to other vaccinators are all assumed to be second vaccine doses.

25 May 2021 | 16:15 PM

Vaccination figures: 17 to 23 May 2021

By Sunday 23 May, it is estimated that more than 8.4 million vaccinations had been administered in the Netherlands. More than 6.1 million of those were first vaccinations, and 2.3 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard

Vaccination coverage based on GGD data
The number of people vaccinated by the GGD is rising rapidly every week. Vaccination coverage among people aged 55-59 has risen to 42% for the first vaccination. Vaccination coverage for people aged 50-54 has been included for the first time, and has now reached 16% for the first vaccination.

Vaccination coverage among people over 65 living at home has also increased and varies somewhat per age group, ranging from 73% to 91% for the first vaccination. Coverage in these age groups continues to rise slightly every week. People aged 60-64 years are not included in these charts displaying GGD data, since that age group is primarily vaccinated by their GPs.

Number of vaccinations given
This weekly update is based on the number of vaccinations registered by the Municipal Public Health Services (GGDs) and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.

Vaccination figures 6 January to 23 May 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 19 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Age groups (including healthcare workers) vaccinated by GGD2   COM/AZ/MOD      
  • People aged 90 and up
26 January 2021      67,802    62,198 130,000
  • 85-89 years
29 January 2021     188,890 174,689 363,579
  • 80-84 years
05 February 2021     374,898 347,665 722,563
  • 75-79 years
06 March 2021     563,578 460,534 1,024,112
  • 70-74 years
06 April 2021     813,695 336,600 1,150,295
  • 65-69 years
19 April 2021     717,866 40,202 758,068
  • 60-64 years
       62,067 42,376 104,443
  • 55-59 years
27 April 2021     525,395 51,648 577,043
  • 50 -54 years
20 May 2021     204,613 44,783 249,398
  • 45 - 49 years
       140,507 32,300 172,807
  • 40 - 44 years
       101,353 24,239 125,592
  • 35 - 39 years
       81,381 20,383 101,764
  • 30 - 34 years
       73,234 19,370 92.604
  • 25 - 29 years
       69,031 19,610 88,641
  • 20 - 24 years
       74,600 24,246 98,846
  • <20 years
       34,312 10,444 44,756
  • Age not specified
            833      147       980
Vaccinated by GPs (estimated)3,4 15 February 2021 AZ 1,228,601  226,737 1,455,338
Vaccinated by other vaccinators (estimated)3,5,6 06 January 2021 COM/MOD/AZ/JANSS   830,697  366,391 1,197,088
Total     6,153,355 2,304,562 8,457,917
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
  2. The Municipal Public Health Services (GGDs) vaccinates people living at home who are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups), care workers (from 6 January 2021 on), people who would normally be eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the first group. On the Wadden Islands, vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog). People aged 60-64 years will primarily be vaccinated with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD. 
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment  National Institute for Public Health and the Environment   is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of AZ will be administered from week 18 on; based on the rollout schedule for AZ and the number of inhabitants per province, the distribution of AZ vaccinations administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
  5. 142,069 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
  6. For AZ, the same assumption is used as for vaccinations by general practitioners (see footnote 4). For MOD, all second doses are assumed to have been given exactly 4 weeks after the first dose. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, deliveries to other vaccinators are all assumed to be second vaccine doses.

 


18 May 2021 | 16:15 PM

Vaccination figures: 10 to 16 May 2021

By Sunday 16 May, it is estimated that more than 7.4 million vaccinations had been administered in the Netherlands. More than 5,6 million of those were first vaccinations, and nearly 1.8 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard

Vaccination coverage based on GGD data 
As of this week, charts displaying vaccination coverage will be provided again. They show vaccination coverage per age group based on the data provided by the Municipal Public Health Services (GGDs). The number of people vaccinated by the GGD is now rising rapidly every week. Among people aged 65 years and older living at home, vaccination coverage is now over 70% for the first vaccination and is still increasing. Vaccination coverage among all people over 65 is higher than what is being reported based on GGD figures, because this group also includes people in residential institutions and people who were vaccinated by their GP. People aged 60-64 years are not included in these charts. This age group is mainly vaccinated by their GPs, and the data records on those vaccinations are not yet complete.

Number of vaccinations given
This weekly update is based on the number of vaccinations registered by the Municipal Public Health Services (GGDs) and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.

Vaccination figures 6 January to 16 May 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 19 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Age groups (including healthcare workers) vaccinated by GGD2   COM/AZ/MOD      
  • People aged 90 and up
26 January 2021      67,584    61,386 128,970
  • 85-89 years
29 January 2021     188,360   172,739   361,099
  • 80-84 years
05 February 2021     373,439   341,726   715,165
  • 75-79 years
06 March 2021     558,072   322,516   880,588
  • 70-74 years
06 April 2021     802,828   146,983   949,811
  • 65-69 years
19 April 2021     704,934    16,417   721,351
  • 60-64 years
       60,773    40,814   101,587
  • 55-59 years
27 April 2021     359,812    49,536   409,348
  • 50 -54 years
      126,847    42,794   169,641
  • 45 - 49 years
       90,420    30,659   121,079
  • 40 - 44 years
       67,020    22,730    89,750
  • 35 - 39 years
       55,203    19,036    74,239
  • 30 - 34 years
       50,781    18,153    68,934
  • 25 - 29 years
       48,235    18,256    66,491
  • 20 - 24 years
       54,660    22,797    77,457
  • <20 years
       23,777     9,912    33,689
  • Age not specified
         770      128      898
Vaccinated by GPs (estimated)3,4 15 February 2021 AZ 1,228,601    90,322 1,318,923
Vaccinated by other vaccinators (estimated)3,5,6 06 January 2021 COM/MOD/AZ/JANSS   799,914   359,995 1,159,909
Total     5,662,030 1,786,899 7,448,929
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
  2. 2.    The Municipal Public Health Services (GGDs) vaccinates people living at home who are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups), care workers (from 6 January 2021 on) and people who would normally be eligible for the influenza vaccination (from 6 May 2021). The start date in the table refers to the former group. On the Wadden Islands, vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog). People aged 60-64 years will primarily be vaccinated with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021), inhabitants of the Wadden Islands (from 16 February 2021), and people who would normally be eligible for the influenza vaccination. Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD. 
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment   is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of AZ will be administered from week 18 on; based on the rollout schedule for AZ and the number of inhabitants per province, the distribution of AZ vaccinations administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19.
  5. 124,373 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
  6. For AZ, the same assumption is used as for vaccinations by general practitioners (see footnote 4). For MOD, all second doses are assumed to have been given exactly 4 weeks after the first dose. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other 

 


11 May 2021 | 16:30 PM

Vaccination figures: 3 to 9 May 2021

By Sunday 9 May, it is estimated that more than 6.4 million vaccinations had been administered in the Netherlands. Almost 5 million of those were first vaccinations, and over 1.4 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard

Last week, GPs started administering the second vaccination, primarily to people aged 60-64 years. People over 65 who did not respond to the invitation for vaccination earlier can still make an appointment: Calling all people over 65: make a vaccination appointment now

Number of vaccinations given
This weekly update is based on the number of vaccinations registered by the Municipal Public Health Services (GGDs) and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.
 

Vaccination figures 6 January to 9 May 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 18 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Older people living at home vaccinated by the GGD2          
  • People aged 90 and up
26 January 2021 COM 67,112 60,713 127,825
  • 85-89 years
29 January 2021 COM 186,785 170,996 357,781
  • 80-84 years
05 February 2021 COM 370,079 336,728 706,807
  • 75-79 years
06 March 2021 COM 550,946  230,068 781,014
  • 70-74 years
06 April 2021 COM 783,223     49,591 832,814
  • 65-69 years
19 April 2021 COM 592,880     13,810 606,690
  • 60-64 years
diverse COM/AZ  59,357      36,918    96,275
  • 55-59 years
27 April 2021    173,845      43,875 217,720

Other people vaccinated by the GGD

06 January 2021 COM/AZ 353,256 156,965 510,221
Vaccinated by GPs (estimated)3 15 February 2021 AZ 1,115,125       41,945 1,157,070
Vaccinated by other vaccinators (estimated)3,4,5 06 January 2021 COM/MOD/AZ/JANSS 738,620 329,659  1,068,279
Total     4,991,228 1,471,268 6,462,496
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
  2. The Municipal Public Health Services (GGDs) will vaccinate people living at home who are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups) and care workers. The start date in the table refers to the former group. On the Wadden Islands, vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog). The GGD already started vaccinating care workers from 6 January on. In principle, people aged 60-64 years will be invited for vaccination with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are therefore not the entire age group who are living at home, but primarily care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be contacted by their GP and offered a vaccination. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment   is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. Second doses of AZ will be administered from week 18 on; based on the rollout schedule for AZ and the number of inhabitants per province, the distribution for week 18 is assumed to be 60% first dose and 40% second dose for AZ vaccinations administered by GPs.
  5. 95,466 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
  6. For AZ, the same assumption is used as for vaccinations by general practitioners (see footnote 4). For MOD, all second doses are assumed to have been given exactly 4 weeks after the first dose. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other 

04 May 2021 | 17:00 PM

Vaccination figures: 26 April to 2 May 2021

By Sunday 2 May, it is estimated that more than 5.6 million vaccinations had been administered in the Netherlands. More than 4.4 million of those were first vaccinations, and over 1.2 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard

Number of vaccinations given

The update for the past week shows the number of vaccinations that have been given. This report now also includes the age groups of 55-59 years and 60-64 years among the groups vaccinated by the Municipal Public Health Services (GGDs). Within the latter age group, people are usually vaccinated by their GPs, but in special situations may be vaccinated by the GGD. This could include care workers or people living on the Wadden Islands.

This weekly update is based on the number of vaccinations registered by the GGD and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.

Vaccination figures 6 January to 2 May 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 17 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Older people living at home vaccinated by the GGD2          
  • People aged 90 and up
26 January 2021 COM 66,623 60,006 126,629
  • 85-89 years
29 January 2021 COM 184,976 169,095 354,071
  • 80-84 years
05 February 2021 COM 367,143 329,635 696,778
  • 75-79 years
06 March 2021 COM 542,819  133,453 676,272
  • 70-74 years
06 April 2021 COM 744,418     4,738 749,156
  • 65-69 years
19 April 2021 COM 360,019    12,404 372,423
  • 60-64 years
diverse COM/AZ   58,296    32,415    90,711
  • 55-59 years
27 April 2021     89,310    37,814 127,124

Other people vaccinated by the GGD

06 January 2021 COM/AZ 318,505 130,806 449,311
Vaccinated by GPs (estimated)3 15 February 2021 AZ 1,052,207               0 1,052,207
Vaccinated by other vaccinators (estimated)3,4,5 06 January 2021 COM/MOD/AZ/JANSS 664,414 292,747  957,161
Total     4,448,730 1,203,113 5,651,843
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
  2. Vaccinations for older people are being provided not only by the Municipal Public Health Services (GGDs), but also by GP practices. This is arranged when people are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups). In principle, people aged 60-64 years will be invited for vaccination with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021) who have been vaccinated by the GGD with the AstraZeneca vaccine or Comirnaty®. People born in 1955, 1954 and 1953 (aged 65-67 years) who are living in the provinces of Groningen, Friesland, Drenthe, Overijssel, Noord-Holland and Zeeland may also be contacted by their GP and offered a vaccination. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD. Since we cannot identify these people separately, they have been included in this category.
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
  4. 8,883 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
  5. Up to and including week 12, deliveries to care institutions that involved the same product (brand name and storage conditions) that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. When it is not possible to determine whether it involved first or second doses (which is the case for 53,506 vaccinations), then the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17, this assumption is applied for all vaccinators except for the GGD and GPs, and is not applied for AZ. It is assumed that all second doses of Moderna were administered exactly 4 weeks after the first doses.

20 April 2021 | 16:00 PM (revision 28-04-2021)

Vaccination figures: 12 to 18 April 2021

By Sunday 18 April, it is estimated that more than 4.3 million vaccinations had been administered in the Netherlands. Almost 3.4 million of those were first vaccinations, and almost 1 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.

Number of vaccinations given
The update for week 15 shows the number of vaccinations that have been given. This is based on the number of vaccinations registered by the GGD and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.

Number of vaccine doses delivered
The number of doses of COVID-19 vaccines delivered to the Netherlands will now be displayed on the Coronavirus Dashboard.

Vaccination figures 6 January to 18 April 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 15 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Older people living at home vaccinated by the GGD2          
  • People aged 90 and up
26 January 2021 COM 65,393 58,372 123,765
  • 85-89 years
29 January 2021 COM 181,906 162,770 344,676
  • 80-84 years
05 February 2021 COM 360,218 289,845 650,063
  • 75-79 years
06 March 2021 COM 474,724  37,456 512,180
  • 70-74 years
06 April 2021 COM 355,683     2,423 358,106

Other people vaccinated by the GGD

06 January 2021 COM/AZ 458,394 208,146 666,540
Vaccinated by GPs (estimated)3 15 February 2021 AZ 862,524               0 862,524
Vaccinated by other vaccinators (estimated)3,4 06 January 2021 COM/MOD/AZ 605.016 235.085 840,101
Total     3.363.858 994.097 4,357,955
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); for all the vaccines currently being used, 2 doses are recommended.
  2. In some cases, people aged 70 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD); and people born in 1947 and 1948 were able to make an appointment slightly sooner than when they received an invitation.
  3. A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed from week 13 on that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for Vaxzevria® (AstraZeneca). In principle, these assumptions have not been changed for the period from week 1 through 12 and can be found in the report of 30 March 2021; however, the projected wastage for these first 12 weeks has been retroactively reduced from 5% to 1%. This estimate is updated frequently as more information becomes available.
  4. Up to and including week 12, deliveries of the Pfizer/BioNTech vaccine to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. When it is not possible to determine whether it involved first or second doses (which is the case for 48,057 vaccinations), then the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).    It is assumed that all second doses of Moderna were administered exactly 4 weeks after the first doses.

13 April 2021 | 10:30 PM (revision 28-04-2021)

Vaccination figures: 5 to 11 April 2021

The COVID-19 vaccination figures published today in the RIVM report and on the Corona Dashboard are higher than in previous weeks. The news item about the vaccination figures provides further details on this increase.
By Sunday 11 April, it is estimated that nearly 3.5 million vaccinations had been administered in the Netherlands. Almost 2.7 million of those were first vaccinations, and over 900,000 were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.

Number of vaccinations given

The update for week 14 shows the number of vaccinations that have been given. This is based on the number of vaccinations administered by the GGD and estimates based on the number of doses delivered to other vaccinators.

Number of vaccine doses delivered

In week 14, the Netherlands received 487,890 doses of the Pfizer/BioNTech vaccine and 55,440 doses of the AstraZeneca vaccine.

Vaccination figures 6 January to 11 April 2021

Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine,  week 1 to week 14 (2021), by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Older people living at home vaccinated by the GGD2          
  • People aged 90 and up
26 January 2021 COM 64,514 56,751 121,265
  • 85-89 years
29 January 2021 COM 179,931 156,123 336,054
  • 80-84 years
05 February 2021 COM 354,126 241,389 595,515
  • 75-79 years
06 March 2021 COM 339,357 16,927 356,284
  • 70-74 years
06 April 2021 COM  158,082 2,007 160,089

Other people vaccinated by the GGD

06 January 2021 COM/AZ 428,410 205,150 633,560
Vaccinated by GPs (estimated)3 15-02-2021 AZ 583,254               0 583,254
Vaccinated by other vaccinators (estimated)3,4 06-01-2021 COM/MOD/AZ 553.078 225.164 778,242
Total     2.660.752 903.511 3,564,263
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); for all the vaccines currently available, 2 doses are recommended.
  2. In some cases, people aged 70 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD); and people born in 1947 and 1948 were able to make an appointment slightly sooner than when they received an invitation.
  3. A continuous data flow into the national registration system (CIMS) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). It is assumed that deliveries of deep-frozen Comirnaty® are used within ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that Vaxzevria® (AstraZeneca) is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). For deliveries of Vaxzevria® (AstraZeneca) or COVID-19 Vaccine Moderna® to institutions or hospitals, it is assumed that the vaccines are administered over the course of ten working days. RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for Vaxzevria® (AstraZeneca).
  4. Up to and including week 12, deliveries of the Pfizer/BioNTech vaccine to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. When it is not possible to determine whether it involved first or second doses (which is the case for 36,033 vaccinations), then the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose).     It is assumed that all second doses of Moderna were administered exactly 4 weeks after the first doses.

09 April 2021 | 18:15 PM

Weekly update on COVID-19 vaccination: 29 March to 4 April 2021

By Sunday 4 April, it is estimated that more than 2.8 million vaccinations had been administered in the Netherlands. In week 13, the Netherlands received 326,430 doses of the Pfizer/BioNTech vaccine, 145,200 doses of the Moderna vaccine and 430,320 doses of the AstraZeneca vaccine.

The update for week 13, like previous weekly updates, provides estimates of the total number of vaccinations administered based on the number of vaccines delivered. However, it is no longer possible for all vaccinators to distinguish between the total number of first and second doses. This is because the same target groups can now receive both their first vaccination and second vaccination. It is also no longer possible to calculate vaccination coverage for elderly people living at home, since vaccinations for this group are now being provided not only by the Municipal Public Health Services (GGDs), but also by GP practices.  RIVM is currently only receiving complete information on the number of vaccinations administered to people who were vaccinated by the GGD. 

A daily estimate of the number of vaccinations that have been administered is available on the Coronavirus Dashboard provided by the Dutch national government.

Vaccination figures 6 January to 4 April 2021

Table: Number of people who received a first and possibly also second dose of COVID-19 vaccine, 1 January to 4 April 2021, by type of vaccinator.

Target group Start date Vaccine1 First dose Second dose Total4
Thuiswonende ouderen gevaccineerd door de GGD2          
  • People aged 90 and up
26 January 2021 COM 63.731 54.566 118.297
  • 85-89 years
29 January 2021 COM 177.945 145.706 323.651
  • 80-84 years
05 February 2021 COM 346.431 157.544 503.975
  • 75-79 years
06 March 2021 COM 242.759    7.303 250.062
  • 70-74 years
06 April 2021 COM  54.790    1.670  56.460

Other people vaccinated by the GGD

06 January 2021 COM/AZ 423.573 202.057 625.630
Vaccinated by GPs (estimated)3 15-02-2021 AZ 331.774               0 331.774
Vaccinated by other vaccinators)3,4 06-01-2021 COM/MOD/AZ 416.559 237.578 654.137
Totaal     2.057.562 806.424 2.863.986
  1. COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); for all the vaccines currently available, 2 doses are recommended.
  2. In some cases, people aged 70 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD); and people born in 1947 and 1948 were able to make an appointment slightly sooner than when they received an invitation.
  3. A continuous data flow into the national registration system (CIMS) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). It is assumed that deliveries of deep-frozen Comirnaty® are used within ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that Vaxzevria® (AstraZeneca) is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). For deliveries of Vaxzevria® (AstraZeneca) or COVID-19 Vaccine Moderna® to institutions or hospitals, it is assumed that the vaccines are administered over the course of ten working days. RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for Vaxzevria® (AstraZeneca).
  4. From week 13 onwards, no distinction can currently be made between first and second doses for vaccinations carried out by other vaccinators, and the first and second doses are allocated pro rata based on the distribution up to and including week 12 for other vaccinators (i.e. 64% first dose, 36% second dose). That distinction can be made again once the national registration system (CIMS) can be used to generate reports.

30 March 2021 | 16:00 PM

Weekly update on COVID-19 vaccination: 21 to 28 March 2021

By Sunday 28 March, it is estimated that nearly 1.7 million people in the Netherlands had received at least one COVID-19 vaccination, and nearly 700,000 people had received their second vaccination. 

Vaccination coverage

The preliminary COVID-19 vaccination coverage for people over 90 living at home has reached 68% for the first vaccination and 55% for the second vaccination. Among people aged 85-89 living at home, vaccination coverage has reached 79% for the first vaccination and 57% for the second. For people aged 80-84 living at home, vaccination coverage is at 82% for the first vaccination and 24% for the second. Vaccination coverage for the first COVID-19 jab has risen to 23% of people aged 75-79 living at home. 

Vaccination coverage is no longer increasing as rapidly in the over-80 age groups. People in these age groups can still schedule a vaccination appointment with the Municipal Public Health Service (GGD), by calling the national appointment scheduling centre; the phone number is provided in the invitation letter. 
Starting next week, eligible people who are not mobile enough to come to a vaccination site will be vaccinated at home. The GP will vaccinate them using the AstraZeneca vaccine. The vaccines will be delivered in phases per province. The GPs in Drenthe will receive extra vaccines for this group at the end of this week. Next week, deliveries will be made to GPs in North Holland, Overijssel, Groningen and Friesland. Other provinces will then start vaccinating eligible people living at home who are unable to travel, once enough vaccines have been delivered to supply those doses as well. 

Vaccine deliveries

In the past week, the Netherlands received 326,430 doses of the Pfizer/BioNTech vaccine and 44,880 doses of the AstraZeneca vaccine.

Reporting

RIVMNational Institute for Public Health and the Environment will soon start posting updates on the vaccination figures from the COVID-19 vaccination Information and Monitoring System (CIMS). 
 

Vaccination figures 6 January to 28 March 2021

Target group Start date Vaccine First dose Second dose

Care workers providing direct COVID-19 care

06-01-2021 COM   40,000 40,000

GPs

22-01-2021 MOD  14,300   14,050
Other care workers & older people living at home <75 years 06-01-2021 COM/AZ 400,946 201,123
Living at home        
90 years and up living at home 26-01-2021 COM  62,986 50,953
85-89 years 29-01-2021 COM 175,827 127,491
80-84 years 05-02-2021 COM 338,640 97,129
75-79 years 06-03-2021 COM  144,754 4,400
60-64 years and/or high risk of severe COVID-19 (estimated) 15-02-2021 AZ 198,945        0
Long-term residential care institutions (estimated)        
  • Nursing homes and care institutions with an institutional physician  & GGZ
18-01-2021 COM/MOD/AZ 199,827 149,497
  • Small-scale residential facilities under GP care 
25-01-2021 MOD/COM  112,265 5,419
Total     1,688,490

690,062

  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
  • Direct COVID-19 care and GPs: rounded figures.
  • Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
  • In some cases, people aged 75 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; and some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD).
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
  • People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
  • COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
  • A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.
  • As a precautionary measure as advised by the Dutch Medicines Evaluation Board (CBG-MEB), vaccination with the AstraZeneca vaccine was temporarily on hold in week 11.

23 March 2021 | 16:15 PM

Weekly update on COVID-19 vaccination: 14 to 21 March 2021

By Sunday 21 March, it is estimated that nearly 1.5 million people in the Netherlands had received at least one COVID-19 vaccination, and more than 600,000 people had received their second vaccination. The 2 millionth vaccination was administered last week, on 19 March.

Vaccination with the AstraZeneca vaccine was temporarily on hold, which affected last week’s vaccination figures. As a result of the temporary hold, people aged 60-64, people with Down’s syndrome, people with morbid obesity, and patients and employees in mental healthcare institutions and in long-term care were not vaccinated with the AstraZeneca vaccine last week. Vaccination with the AstraZeneca vaccine started again this week.

Vaccination coverage

The preliminary COVID-19 vaccination coverage for people over 90 living at home has reached 67% for the first vaccination and 48% for the second vaccination. Among people aged 85-89 living at home, vaccination coverage has reached 78% for the first vaccination and 45% for the second vaccination. Vaccination coverage among people aged 80-84 living at home has risen to 80% for the first vaccination and 13% for the second vaccination. Vaccination coverage for the first COVID-19 jab has risen to 15% of people aged 75-79 living at home. 

Most people in the over-80 age groups have received their vaccination(s). Vaccination coverage in these age groups is increasing less rapidly than in the first weeks after vaccination started. There are people in these age groups who have not yet been vaccinated. It is important for people in these age groups who want to be vaccinated to schedule an appointment as soon as possible. Everyone in these older age groups can now schedule a vaccination appointment with the Municipal Public Health Service (GGD). They can make an appointment by calling the national appointment scheduling centre; the phone number is provided in the invitation letter. In the very near future, GPs will start providing vaccinations for elderly people living at home who are not mobile enough to come to the GGD. 

Vaccine deliveries

In the past week, the Netherlands received 218,790 doses of the Pfizer/BioNTech vaccine, 44,880 doses of the AstraZeneca vaccine, and 96,000 doses of the Moderna vaccine.

Reporting

RIVMNational Institute for Public Health and the Environment will soon start reporting on the vaccination figures from the COVID-19 vaccination Information and Monitoring System (CIMS). Based on the data in CIMS, it will be possible to show vaccination coverage by age group, region, municipality and gender. It will still be possible to display a breakdown of vaccination figures based on which vaccine brand was administered and which type of implementing party administered it. The breakdown by target group (care workers, general practitioners, institutional residents and people at high risk for severe COVID-19) will no longer be provided.
 

Vaccination figures 6 January to 21 March 2021

Target group Start date Vaccine First dose Second dose

Care workers providing direct COVID-19 care

06-01-2021 COM   40,000 40,000

GPs

22-01-2021 MOD  14,300   14,050
Other care workers & older people living at home <75 years 06-01-2021 COM/AZ 360,417 198,194
Living at home        
90 years and up living at home 26-01-2021 COM  62,328 44,874
85-89 years 29-01-2021 COM 173,620 99,124
80-84 years 05-02-2021 COM 328,646 51,984
75-79 years 06-03-2021 COM    94,649 2,349
60-64 years and/or high risk of severe COVID-19 (estimated) 15-02-2021 AZ 154,803        0
Long-term residential care institutions (estimated)        
  • Nursing homes and care institutions with an institutional physician  & GGZ
18-01-2021 COM/MOD/AZ 171,929 149,497
  • Small-scale residential facilities under GP care 
25-01-2021 MOD/COM  91,797     5,419
Total     1,492,489

605,491

  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
  • Direct COVID-19 care and GPs: rounded figures.
  • Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
  • In some cases, people aged 75 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; and some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD).
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
  • People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
  • COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
  • A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.
  • As a precautionary measure as advised by the Dutch Medicines Evaluation Board (CBG-MEB), vaccination with the AstraZeneca vaccine was temporarily on hold in week 11.

16 March 2021 | 16:10 PM

Weekly update on COVID-19 vaccination: 8 to 14 March 2021

By Sunday 14 March, it is estimated that nearly 1.4 million people in the Netherlands had received at least one COVID-19 vaccination, and nearly 500,000 people had received their second vaccination.

Vaccination coverage
The preliminary COVID-19 vaccination coverage for people over 90 living at home has risen to 66% for the first vaccination and 37% for the second vaccination. Among people aged 85-89 living at home, vaccination coverage has reached 76% for the first vaccination and more than 21% for the second vaccination. Vaccination coverage for the first COVID-19 jab has reached 74% of people aged 80-84 living at home, and 7% of people aged 75-79 living at home.

People from these age groups can still schedule a vaccination appointment with the Municipal Public Health Service (GGD). Vaccination will also start shortly for non-mobile elderly people living at home who cannot come to the GGD for an appointment. 

Vaccine deliveries
In the past week, the Netherlands received 218,790 doses of the Pfizer/BioNTech vaccine and 95,040 doses of the AstraZeneca vaccine. There were no vaccine deliveries from Moderna in the past week. 
 

Vaccination figures 6 January to 14 March 2021

Target group Start date Vaccine First dose Second dose

Care workers providing direct COVID-19 care

06-01-2021 COM   40,000 40,000

GPs

22-01-2021 MOD  14,300   13,300
Other care workers & older people living at home <75 years 06-01-2021 COM/AZ 356,972 196,083
Living at home        
90 years and up living at home 26-01-2021 COM  61,258 34,345
85-89 years 29-01-2021 COM 169,045 47,681
80-84 years 05-02-2021 COM 305,321 5,713
75-79 years 06-03-2021 COM    44,066    572
60-64 years and/or high risk of severe COVID-19 (estimated) 15-02-2021 AZ 154,803        0
Long-term residential care institutions (estimated)        
  • Nursing homes and care institutions with an institutional physician  & GGZ
18-01-2021 COM/MOD/AZ 168,241 150,010
  • Small-scale residential facilities under GP care 
25-01-2021 MOD/COM  80,597     5,419
Total     1,394,603

493,123

content footnote

  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
  • Direct COVID-19 care and GPs: rounded figures.
  • Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
  • In some cases, people aged 75 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; and some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD).
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
  • People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
  • COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
  • A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.

09-03-2021 | 16:30 uur

Vaccinatiecijfers 28 februari tot en met 7 maart 2021

Tot en met zondag 7 maart hebben naar schatting ruim 1,2 miljoen mensen in Nederland tenminste één coronavaccinatie ontvangen en ruim 400.000 mensen een tweede vaccinatie.

Vaccinatiegraad

De voorlopige vaccinatiegraad onder de thuiswonende 90-plussers staat op 64% voor de eerste vaccinatie en op 12% voor de tweede vaccinatie. De vaccinatiegraad onder thuiswonende 85-89-jarigen voor de eerste vaccinatie is 73% en bij de thuiswonende 80-84-jarigen is dat 63%. Onder de thuiswonende 75-79-jarigen is er een klein aandeel van 3% dat een eerste vaccinatie heeft gehad.

De leeftijdsgroep 75-79-jarigen ontvangt sinds afgelopen week een uitnodiging. Een klein aantal heeft iets eerder een eerste vaccinatie ontvangen. Het kan gaan om mensen die gelijk met de groep 80-84-jarigen zijn uitgenodigd, maar die toen nog net geen 80 waren en inwoners van de Waddeneilanden.

Toegeleverde vaccins

In de afgelopen week heeft Nederland 208.260 doses vaccin van BioNTech/Pfizer toegeleverd gekregen en van AstraZeneca 216.480 doses. Moderna heeft in de afgelopen week geen vaccins geleverd.

Vaccinatiecijfers 6 januari t/m 7 maart 2021

Doelgroep Startdatum Vaccin Eerste dosis Tweede dosis

Directe COVID-19-zorgmedewerkers

06-01-2021 COM   40.000 40.000

Huisartsen

22-01-2021 MOD 14.300 8.300
Andere zorgmedewerkers & thuiswonende ouderen <75 jaar 06-01-2021 COM/AZ 304.991 195.581
Thuiswonenden        
  • 90-plussers
26-01-2021 COM 59.162 11.421
  • 85-89-jarigen
29-01-2021 COM 161.916 1.376
  • 80-84-jarigen
05-02-2021 COM 259.307 338
  • 75-79 jarigen 
06-03-2021 COM 19.259 289
  • 60-64-jarigen & hoog risico ernstig beloop COVID-19 (schatting)
15-02-2021 AZ 120.674 0
Bewoners instellingen voor langdurige zorg (schatting)        
  • Verpleeghuizen en zorginstellingen met instellingsarts & GGZ geestelijke gezondheidszorg 
18-01-2021 COM/MOD/AZ 162.603 149.711
  • Kleinschalige woonvormen vallend onder huisarts
25-01-2021 MOD/COM 65.692 4.919
Totaal     1.207.904 411.935
  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
  • Direct COVID-19 care and GPs: rounded figures.
  • Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
  • In some cases, people aged 75 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; and some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD).
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
  • People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
  • COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
  • A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment  National Institute for Public Health and the Environment   is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.

02-03-2021 | 16:45 PM

Weekly update on COVID-19 vaccination: 21 to 28 February 2021

By Sunday 28 February, it is estimated that more than 1,000,000 people in the Netherlands had received at least one COVID-19 vaccination.

Vaccination started last week for mental health clients in inpatient or residential care at four large institutions and the mental healthcare workers employed there; they are being vaccinated by the institution’s own medical department. District nurses also started receiving their vaccinations last week.

Vaccination coverage among elderly people living at home has increased. The first COVID-19 jab for those living at home has been given to 61% of people over 90, 68% of people aged 85-89, and 42% of people aged 80-84. These percentages will increase even more in the next few weeks, when more people from these groups have received their vaccinations.

Second vaccination
More than 331,000 people are estimated to have received their second vaccination.

Vaccine deliveries
In the past week, the Netherlands received 200,070 doses of the Pfizer/BioNTech vaccine, 72,000 doses of the Moderna vaccine and 148,390 doses of the AstraZeneca vaccine. 
 

Vaccination figures 6 January to 21 February 2021

Target group Start date Vaccine First dose Second dose

Care workers providing direct COVID-19 care

06-01-2021 COM   40,000 40,000

GPs

22-01-2021 MOD 14,300 3,000
Other care workers & older people living at home <80 years 06-01-2021 COM/AZ 297,919 192,556
90 years and up living at home 26-01-2021 COM 56,747 196
85-89 years 29-01-2021 COM 150,859 200
80-84 years 05-02-2021 COM 172,523 214
60-64 years and/or high risk of severe COVID-19 (estimated) 15-02-2021 AZ 63,002 0
Long-term residential care institutions (estimated)        
  • Nursing homes and care institutions with an institutional physician  & GGZ
18-01-2021 COM/MOD/AZ 156,477 92,988
  • Small-scale residential facilities under GP care 
25-01-2021 MOD/COM 52,930 2,517
Total     1,004,757

331,671

  • ambulances for COVID-19 care.
  • Direct COVID-19 care and GPs: rounded figures.
  • Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
  • People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
  • COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
  • A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment  National Institute for Public Health and the Environment   is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.

16-2-2021 | 16:00 PM

Weekly update on COVID-19 vaccination: 7 to 14 February 2021

By Sunday 14 February 2021, it is estimated that about 629,000 people in the Netherlands had received their first COVID-19 vaccination. Starting last week, the first care workers in disability care and rehabilitation care are receiving their first vaccination with the AstraZeneca vaccine. Nursing home staff who had not been able to schedule an appointment yet are also included in this round. 

GP practices also started vaccinations yesterday for the first people aged 60-64 and for people who have a high risk of severe illness resulting from COVID-19. In this round, this concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). They will also receive the AstraZeneca vaccine.

Second vaccination
More than 154,400 people are estimated to have received their second vaccination. With the current vaccines, a second vaccination is required for optimal protection against the coronavirus SARS-CoV-2.

Vaccine deliveries
In the past week, the Netherlands received 159,120 doses of the Pfizer/BioNTech vaccine, 95,040 doses of the AstraZeneca vaccine and 38,400 doses of the Moderna vaccine.

Vaccination figures 6 January to 14 February 2021

Target group Start date Vaccine First dose Second dose

Care workers providing direct COVID-19 care

06-01-2021 COM   40,000 40,000

Nursing home staff/people aged 80+ living at home

06-01-2021 COM/AZ 414,776 97,616

GPs

22-01-2021 MOD 14,300 0
People living in long-term care institutions (estimated)        
People living in nursing homes and care institutions with an institutional physician  18-01-2021 COM 152,006 16,829
People living in small-scale residential facilities under GP care  25-01-2021 MOD 7,911 0
Total     628,993 154,445
  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care. 
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions. 
  • Direct COVID-19 care and GPs: rounded figures. 
  • COM=Comirnaty® (BioNTech/Pfizer); MOD= COVID-19 Vaccine Moderna®; two doses are recommended for the vaccines that are currently available. 
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate between nursing home employees and people aged 80+ living at home. 
  • A continuous data flow for the number of vaccinated people in institutions is not yet available. Therefore, an estimate based on the number of doses issued to vaccination sites is temporarily used for this target group. This estimate is based on the numbers of doses issued to the vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment . These doses are administered on the day that they are provided and during the following three days. The assumption here is that this is done in equal segments (25% per day). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech) and 10 doses per vaccine vial for COVID-19 Vaccine Moderna®.

9-2-2021 | 16:20 PM

Weekly update on COVID-19 vaccination: 1 to 7 February 2021

By Sunday 7 February, more than 500,000 people in the Netherlands had received their first COVID-19 vaccination. That also includes about 13,600 GPs. Last Friday, the first people in the age group from 80-84 years received an invitation to make an appointment for a COVID-19 vaccination at a Municipal Public Health Service (GGD).  

Second vaccination
More than 66,000 people have received their second vaccination. 40,000 of these are employed in hospital care directly related to COVID-19. This group is now fully vaccinated. With the current vaccines, a second vaccination is required for optimal protection against the coronavirus SARS-CoV-2.

Vaccine deliveries
The Netherlands received the first vaccines from AstraZeneca last week: 79,200 doses. In addition, another 159,120 doses of the Pfizer/BioNTech vaccine were delivered in the past week.
 

Vaccination figures 6 January to 7 February 2021

Target group Start date Vaccine First dose Second dose

Care workers providing direct COVID-19 care

06-01-2021 COM   40,000 40,000

Nursing home staff/people aged 80+ living at home

06-01-2021 COM 294,633 26,409

GPs

22-01-2021 MOD 13,600 0
People living in long-term care institutions (estimated)        
People living in nursing homes and care institutions with an institutional physician  18-01-2021 COM 151,584 0
People living in small-scale residential facilities under GP care  25-01-2021 MOD 4,919 0
Total     504,736 66,409
  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care. 
  • People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions. 
  • Direct COVID-19 care and GPs: rounded figures. 
  • COM=Comirnaty® (BioNTech/Pfizer); MOD= COVID-19 Vaccine Moderna®; two doses are recommended for the vaccines that are currently available. 
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate between nursing home employees and people aged 80+ living at home. 
  • A continuous data flow for the number of vaccinated people in institutions is not yet available. Therefore, an estimate based on the number of doses issued to vaccination sites is temporarily used for this target group. This estimate is based on the numbers of doses issued to the vaccination sites as ordered by RIVM National Institute for Public Health and the Environment  . These doses are administered on the day that they are provided and during the following three days. The assumption here is that this is done in equal segments (25% per day). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech) and 10 doses per vaccine vial for COVID-19 Vaccine Moderna®.

2-2-2021 | 17:55 PM

Weekly COVID-19 vaccination update: 25-31 January

By Sunday 31 January, 327,834 people in the Netherlands had received their first COVID-19 vaccination. 15,692 healthcare professionals have received their second COVID-19 vaccination by now. Last week, the Netherlands received 191,880 doses of the Pfizer/BioNTech vaccine and 19,200 doses of the Moderna vaccine. 

In addition to the target groups that are already being vaccinated, vaccination of people aged 90 years and up also started this past week. On Friday 29 January, the first people aged 85-89 years received an invitation to make a vaccination appointment at a GGD vaccination site. 

Second vaccination

With the vaccines that are currently in use, a second vaccination is required for optimal protection against the coronavirus SARS-CoV-2. In the week of 25 to 31 January, 13,500 care workers in acute COVID-19 care received a second vaccination. They are now fully vaccinated. The second vaccination round for nursing home employees also started last week.  

Vaccination figures 6 to 31 January 2021

Target group Start date Vaccine Number of people who have started vaccination Number of people who are fully vaccinated

Direct COVID-19 care

06-01-2021 COM   40,000 13,500

Nursing home staff/people aged 85+ living at home

06-01-2021 COM 186,008 2,192

GPs

22-01-2021 MOD 6,000 0
Long-term care institutions (estimated) 18-01-2021 COM/MOD 95,826 0
Total     327.834 15,692
  • Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
  • Direct COVID-19 care and GPs rounded to thousands.
  • Vaccination started = one dose received
  • Fully vaccinated = has received the total number of doses recommended by the manufacturer for that vaccine brand. For the currently available vaccines, this is 2 doses. COM=Comirnaty® (Pfizer/BioNTech); MOD=COVID-19 Vaccine Moderna®.
  • In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate between target groups. For that reason, the table displays the combined group designated ‘Nursing home staff / people aged 85+ living at home’.
  • A continuous data flow for the number of vaccinated people in institutions is not yet available. Therefore, an estimate based on the number of doses delivered to vaccination sites is temporarily used for this target group. This estimate is based on the numbers of doses delivered at the vaccination sites as ordered by RIVM National Institute for Public Health and the Environment  . These doses are administered on the day of delivery itself and during the following three days. The assumption here is that this is done in equal segments (25% per day). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech) and 10 doses per vaccine vial for COVID-19 Vaccine Moderna®.

26-1-2021 | 17:01 PM

More than 160 thousand people vaccinated in total

During the week of 18 to 24 January, more than 80 thousand people were vaccinated. Most of these were mainly care workers. Residents of institutions for people with intellectual disabilities and nursing homes also received their first vaccination. All vaccinated people still need to receive a second vaccination for optimal protection. In total, more than 160,000 people had been vaccinated by 24 January.

As of 19 January, RIVMNational Institute for Public Health and the Environment is publishing a weekly update on figures from the COVID-19 vaccination programme. The coronavirus dashboard provided by the Dutch Government has also started publishing COVID-19 vaccination figures as of today. The RIVM report does not yet include figures on vaccinations in nursing homes and administered to GPs, because a continuous data flow has not yet been achieved.

Nursing home residents, people with intellectual disabilities living in an institution, and GPs

On Monday 18 January, vaccination started for residents of nursing homes and institutions for people with intellectual disabilities. They are receiving the Comirnaty® vaccine manufactured by Pfizer/BioNTech. Based on an initial inventory by RIVM among the 12 nursing homes and care institutions where vaccination has started, approximately 17,000 people have received vaccinations so far. That includes about 2,000 care workers. Vaccination of the first general practitioners (GPs) started on Friday 22 January. They are receiving the COVID-19 Vaccine® manufactured by Moderna. Vaccination roll-out for GPs is still ongoing.

New data

Reporting was expanded this week to include the doses of COVID-19 vaccines that have been delivered. In the week of 18 to 24 January, the Netherlands received 92,430 doses from manufacturer Pfizer/BioNTech. Over 200 thousand vaccinations will be administered this week. At this point, the percentage of vaccinated people in the Dutch population is not yet high enough to have a visible impact on the course of the epidemic.

Vaccination figures 6 to 24 januari 2021

Target group   As of Number of people who have started vaccination
Care workers     146,612
  Hospital employees in acute care 06-01-2021 40,000
  Nursing home employees 06-02-2021 106,612
Total     146,612

• Hospital employees in acute care: nurses and doctors in the intensive care units, emergency department, COVID-19 wards and on ambulance crews.


19-1-2021 | 16:22 uur

Weekly RIVM update on vaccination figures

As of today, RIVM will be publishing an update every Tuesday on figures from the COVID-19-vaccination programme. Initial figures on the number of vaccinations that have been administered will be reported this week. The data will be updated and supplemented in the next few weeks. Eventually, the data will also be available in open data sets and on the coronavirus dashboard provided by the Dutch Government.

The Netherlands started vaccinating on 6 January. By Sunday 17 January, nearly 77,000 care workers in total had received their first COVID-19 vaccination. In hospitals, some 40,000 care workers in acute care directly related to COVID-19 were vaccinated within a week and a half. In the same period, about 37,000 nursing home employees received a vaccine through the Municipal Public Health Services (GGDs).  These people were vaccinated with the Comirnaty® vaccine manufactured by Pfizer/BioNTech and will receive a second vaccination in the coming weeks. Based on the current figures, this has not yet had a visible effect on the course of the epidemic.

Vaccination figures 6 to 17 januari 2021

Target group   Number of people who have started vaccination
Care workers   77,000
  Hospital employees in acute care 40,000
  Nursing home employees 37,000
Total   77,000

• Hospital employees in acute care: nurses and doctors in the intensive care units, emergency department, COVID-19 wards and on ambulance crews.